Processing 00000000.tx.1: An Insulin-Degrading Enzyme Inhibitor Decreases Amylin Degradation, Increases Amylin-Induced Cytotoxicity, and Increases Amyloid Formation in Insulinoma Cell Cultures Robert G. 

Phrase: "An Insulin-Degrading Enzyme Inhibitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0021643:insulin inhibitor [Pharmacologic Substance]
   861   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   861   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   812   C1999216:Inhibitor [Qualitative Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "Decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "Amylin Degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "Increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Amylin-Induced Cytotoxicity,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]

Phrase: "and"

Phrase: "Increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Amyloid Formation in Insulinoma Cell Cultures Robert G."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
Processing 00000000.tx.2: Bennett1,2, Frederick G. 

Phrase: "Bennett1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Frederick G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.3: Hamel1,2, and William C. 

Phrase: "Hamel1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "William C."
Processing 00000000.tx.4: Duckworth3,4,5 1 Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska 2 Department of Medical Research, Veterans Affairs Medical Center, Omaha, Nebraska 3 Endocrinology Section, Carl T. 

Phrase: "Duckworth3,"

Phrase: "4,"

Phrase: "5 1 Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "University of Nebraska Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 2 Department of Medical Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0587450:Medical department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "Veterans Affairs Medical Center,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1549054:Veterans Affairs [Organization]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0042610:Veterans [Population Group]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]
   779 E C3245459:veteran [Intellectual Product]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 3 Endocrinology Section,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "Carl T."
Processing 00000000.tx.5: Hayden VA Medical Center, Phoenix, Arizona 4 Molecular and Cellular Biology Program, Arizona State University, Tempe, Arizona 5 Department of Medicine, University of Arizona, Tucson, Arizona  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Amylin (islet amyloid polypeptide) is the chief component of the islet amyloid found in type 2 diabetes, and amylin fibril precursors may be cytotoxic to pancreatic -cells. 

Phrase: "Hayden VA Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]

Phrase: "Phoenix,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331993:Phoenix [Health Care Related Organization]
  1000   C1080696:Phoenix [Plant]

Phrase: "Arizona 4 Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1521991:Molecular [Qualitative Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Biology Program,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]
   734   C0010819:Cellular Biology [Biomedical Occupation or Discipline]

Phrase: "Arizona State University,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0003787:Arizona [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "Tempe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453232:Tempeh [Food]
  1000   C2718085:TEMPE [Organic Chemical]

Phrase: "Arizona 5 Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "University of Arizona,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003787:Arizona [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Tucson,"

Phrase: "Arizona  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "(islet amyloid polypeptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "is"

Phrase: "the chief component of the islet amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "found in type 2 diabetes,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0150312:Found [Quantitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "amylin fibril precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1709634:Precursor [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "cytotoxic to pancreatic -cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0022686:Cytotoxic cell [Cell]
   770   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   770   C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.6: Little is known about the prevention of amylin aggregation. 

Phrase: "Little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the prevention of amylin aggregation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   748   C0199176:Prevention [Therapeutic or Preventive Procedure]
   748   C0205309:Known [Qualitative Concept]
   748   C0332621:Aggregation [Functional Concept]
   748   C0439168:% aggregation [Quantitative Concept]
   748   C1415831:AMYLIN [Gene or Genome]
   748   C1706420:PREVENTION [Research Activity]
   748   C2700409:prevention [Qualitative Concept]
Processing 00000000.tx.7: We investigated the role of insulin-degrading enzyme (IDE) in amylin degradation, amyloid deposition, and cytotoxicity in RIN-m5F insulinoma cells. 

Phrase: "We"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the role of insulin-degrading enzyme (IDE)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in amylin degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "amyloid deposition,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]

Phrase: "and"

Phrase: "cytotoxicity in RIN-m5F insulinoma cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   731   C0022686:Cytotoxic cell [Cell]
Processing 00000000.tx.8: Human 125I-labeled amylin degradation was inhibited by 46 and 65% with the addition of 100 nmol/l human amylin or insulin, respectively. 

Phrase: "Human 125I-labeled amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "inhibited by 46"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "and"

Phrase: "65% with the addition of 100 nmol/l human amylin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0439282:nmol/L [Quantitative Concept]
   739   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   739   C0086418:Human [Human]
   739   C0439191:NMOLE [Quantitative Concept]
   739   C0450385:65 [Intellectual Product]
   739   C1415831:AMYLIN [Gene or Genome]
   739   C1883712:Addition [Functional Concept]

Phrase: "or"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.9: 125I-labeled insulin degradation was inhibited with 100 nmol/l human amylin, rat amylin, and insulin (by 50, 50, and 73%, respectively). 

Phrase: "125I-labeled insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C3547574:insulin degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "inhibited with 100 nmol/l human amylin,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0439282:nmol/L [Quantitative Concept]
   748   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   748   C0086418:Human [Human]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C0439191:NMOLE [Quantitative Concept]
   748   C1415831:AMYLIN [Gene or Genome]

Phrase: "rat amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "by 50,"

Phrase: "50,"

Phrase: "and"

Phrase: "73%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.10: The IDE inhibitor bacitracin inhibited amylin degradation by 78% and insulin degradation by 100%. 

Phrase: "The IDE inhibitor bacitracin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   708   C0021643:insulin inhibitor [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "amylin degradation by 78%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "insulin degradation by 100%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
Processing 00000000.tx.11: Amyloid staining by Congo red fluorescence was detectable at 100 nmol/l amylin and was pronounced at 1,000 nmol/l amylin treatment for 48 h. 

Phrase: "Amyloid staining by Congo red fluorescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0009742:congo red staining [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   820   C1293958:congo red staining [Laboratory Procedure]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "detectable at 100 nmol/l amylin"

Phrase: "and"

Phrase: "was"

Phrase: "pronounced"

Phrase: "at 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "000 nmol/l amylin treatment for 48 h."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.12: Bacitracin treatment markedly increased staining at all amylin concentrations. 

Phrase: "Bacitracin treatment markedly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "staining at all amylin concentrations."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   760   C0086045:Concentrations [Mental Process]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1415831:AMYLIN [Gene or Genome]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   726 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.13: Bacitracin with amylin caused a dramatic decrease in cell viability compared with amylin alone (68 and 25%, respectively, at 10 nmol/l amylin). 

Phrase: "Bacitracin with amylin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   734 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a dramatic decrease in cell viability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0007620:Cell Viability [Cell Function]
   804   C0443348:viability [Qualitative Concept]

Phrase: "compared with amylin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   790   C1415831:AMYLIN [Gene or Genome]
   790   C1707455:Compared [Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "and"

Phrase: "25%,"

Phrase: "respectively,"

Phrase: "at 10 nmol/l amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   812   C1415831:AMYLIN [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.14: In summary, RIN-m5F cells degraded both amylin and insulin through a common proteolytic pathway. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "both amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin through a common proteolytic pathway."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2984427:Insulin Pathway [Functional Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.15: IDE inhibition by bacitracin impaired amylin degradation, increased amyloid formation, and increased amylin-induced cytotoxicity, suggesting a role for IDE in amylin clearance and the prevention of amylin aggregation. 

Phrase: "IDE inhibition by bacitracin impaired amylin degradation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0877008:enzyme inhibition [Disease or Syndrome]
   764   C1524081:Enzyme Inhibition [Physiologic Function]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "increased amyloid formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "increased amylin-induced cytotoxicity,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   741 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   741 E C1511636:cytotoxic [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role for IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in amylin clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the prevention of amylin aggregation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0199176:Prevention [Therapeutic or Preventive Procedure]
   760   C1706420:PREVENTION [Research Activity]
   760   C2700409:prevention [Qualitative Concept]
Processing 00000000.tx.16: Type 2 diabetes is characterized by the loss of pancreatic -cell mass, accompanied by the presence of islet amyloid deposits in the pancreas (1). 

Phrase: "Type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "characterized by the loss of pancreatic -cell mass,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0877425:pancreatic mass [Finding]
   744   C0007634:Cell [Cell]
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C0577559:Mass [Finding]
   744   C1269647:Cell [Cell]
   744   C1306372:*Mass [Quantitative Concept]
   744   C1517945:Loss [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1880022:Characterized [Activity]
   744   C1948049:Cell [Spatial Concept]
   744   C3152252:Mass [Quantitative Concept]

Phrase: "accompanied by the presence of islet amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits in the pancreas"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   770   C0333562:Deposit [Functional Concept]
   770   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: The major component of islet amyloid is amylin (also known as islet amyloid polypeptide), a polypeptide copackaged and cosecreted with insulin by pancreatic -cells (2). 

Phrase: "The major component of islet amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "is"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "(also"

Phrase: "known as islet amyloid polypeptide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   862   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0205309:Known [Qualitative Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "a polypeptide copackaged"

Phrase: "and"

Phrase: "cosecreted with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.18: It is presently unclear whether islet amyloid merely is a consequence of diabetes or actually contributes to the progression of the disease. 

Phrase: "It"

Phrase: "is"

Phrase: "presently unclear"

Phrase: "whether"

Phrase: "islet amyloid merely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a consequence of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "or"

Phrase: "actually"

Phrase: "contributes to the progression of the disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0242656:Disease Progression [Pathologic Function]
           progression
   774   C1947900:Disease progression NOS [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0449258:Progression [Functional Concept]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.19: However, there is evidence that intermediate precursors of amylin fibrils are cytotoxic to -cells, whereas mature amyloid fibrils are not toxic, suggesting that -cell toxicity may precede deposition of islet amyloid (3,4). 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that intermediate precursors of amylin fibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1709634:Precursor [Idea or Concept]

Phrase: "are"

Phrase: "cytotoxic to -cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0022686:Cytotoxic cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "whereas"

Phrase: "mature amyloid fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "are"

Phrase: "not toxic,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0600688:toxic [Injury or Poisoning]
   861   C1407029:Toxic [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that -cell toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "may"

Phrase: "precede"

Phrase: "deposition of islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0011560:Amyloid deposition [Pathologic Function]
   819   C1705760:Amyloid Deposition [Finding]
   770   C0333562:Deposition [Functional Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.20: Because amylin is continually produced in individuals without type 2 diabetes, the mere presence of amylin is insufficient to induce amylin-induced -cell toxicity and islet amyloid. 

Phrase: "Because"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "is"

Phrase: "continually"

Phrase: "produced in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "without type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "the mere presence of amylin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "insufficient to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205412:Insufficient [Qualitative Concept]
   861   C0231180:Insufficient [Qualitative Concept]
   789 E C0231179:Insufficiency [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "amylin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "induced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "cell toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "and"

Phrase: "islet amyloid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.21: Transgenic animals producing human (amyloidogenic) amylin fail to develop islet amyloid (57), but when additional diabetic traits are introduced, islet amyloid is detected (810). 

Phrase: "Transgenic animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003069:Animals, Transgenic [Animal]
   861   C0003062:Animals [Animal]

Phrase: "producing"

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "(amyloidogenic"

Phrase: ")"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(57"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "when"

Phrase: "additional diabetic traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0599883:traits [Organism Attribute]
   827   C1427926:TRAITS [Gene or Genome]

Phrase: "are"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: ","

Phrase: "islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(810"

Phrase: ")."
Processing 00000000.tx.22: Therefore, there is a protective mechanism that prevents amyloid deposition under normal conditions, but is impaired under diabetic conditions. 

Phrase: "Therefore,"

Phrase: "there"

Phrase: "is"

Phrase: "a protective mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "amyloid deposition under normal conditions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0011560:Amyloid deposition [Pathologic Function]
   806   C1705760:Amyloid Deposition [Finding]
   760   C0333562:Deposition [Functional Concept]

Phrase: "but"

Phrase: "is"

Phrase: "impaired under diabetic conditions."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0221099:Impaired [Functional Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0684336:Impaired [Pathologic Function]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.23: Because proteolysis is a major pathway in the regulation of protein levels, degradation of amylin may contribute to the prevention of islet amyloid aggregation. 

Phrase: "Because"

Phrase: "proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "is"

Phrase: "a major pathway in the regulation of protein levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1704259:Pathway [Molecular Function]
   742   C1705987:Pathway [Conceptual Entity]

Phrase: "degradation of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "may"

Phrase: "contribute to the prevention of islet amyloid aggregation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0199176:Prevention [Therapeutic or Preventive Procedure]
   744   C0332621:Aggregation [Functional Concept]
   744   C0439168:% aggregation [Quantitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1706420:PREVENTION [Research Activity]
   744   C1880177:Contribute [Activity]
   744   C2700409:prevention [Qualitative Concept]
Processing 00000000.tx.24: -cell toxicity and islet amyloid may therefore result from an imbalance in amylin levels because of impaired degradation of amylin. 

Phrase: "-cell toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "and"

Phrase: "islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "therefore"

Phrase: "result from an imbalance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1274040:Result [Functional Concept]
   770   C1397014:Imbalance [Sign or Symptom]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in amylin levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "because of impaired degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "of amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.25: At present, our understanding of the proteolytic pathways that contribute to the degradation of amylin is incomplete. 

Phrase: "At present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "our understanding of the proteolytic pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162340:Understanding [Mental Process]

Phrase: "that"

Phrase: "contribute to the degradation of amylin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1415831:AMYLIN [Gene or Genome]
   753   C1880177:Contribute [Activity]

Phrase: "is"

Phrase: "incomplete."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205257:Incomplete [Quantitative Concept]
  1000   C0728938:incomplete [Quantitative Concept]
  1000   C1548386:incomplete [Idea or Concept]
Processing 00000000.tx.26: The enzyme responsible for the cellular proteolysis of insulin is insulin-degrading enzyme (IDE) (11). 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "responsible for the cellular proteolysis of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "is"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.27: The substrate specificity of IDE is for amyloidogenic polypeptides, including atrial natriuretic peptide (ANP), glucagon, and the -amyloid peptide found in Alzheimers disease, and therefore may act as a scavenger that clears amyloidogenic peptides to prevent amyloid deposition (11,12). 

Phrase: "The substrate specificity of IDE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0038592:Substrate Specificity [Quantitative Concept]
   774   C0178623:enzyme substrate [Chemical Viewed Functionally]
   774   C0678612:enzyme specificity [Natural Phenomenon or Process]
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]
   748   C1710236:Substrate [Manufactured Object]

Phrase: "is for amyloidogenic polypeptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "atrial natriuretic peptide (ANP),"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "the -amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "found in Alzheimers disease,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "therefore"

Phrase: "may"

Phrase: "act as a scavenger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017108:scavenger [Medical Device]
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C1003377:scavenger [Fish]

Phrase: "that"

Phrase: "clears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "amyloidogenic peptides to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "amyloid deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.28: Recently, we showed that amylin was also an IDE substrate (13). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "an IDE substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0178623:enzyme substrate [Chemical Viewed Functionally]
   812   C1710236:Substrate [Manufactured Object]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.29: Therefore, IDE may be involved in controlling the levels of amylin by degradation, similar to its role in regulating the levels of the Alzheimers-related -amyloid peptide (14). 

Phrase: "Therefore,"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "involved in controlling"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0332298:controlling [Functional Concept]
   790   C1314939:Involved [Functional Concept]
   790   C2587213:Controlling [Functional Concept]
   756 E C0243148:control [Qualitative Concept]
   756 E C1550141:Control [Substance]
   756 E C1882979:Control [Conceptual Entity]
   756 E C3274648:Control [Qualitative Concept]

Phrase: "the levels of amylin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "by degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "similar to its role"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "in"

Phrase: "regulating"

Phrase: "the levels of the Alzheimers-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "related -"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.30: Both the GK rat model of type 2 diabetes, in which IDE has been identified as a diabetes susceptibility gene, and the recently described IDE-null mice show impaired glucose metabolism. 

Phrase: "Both"

Phrase: "the GK rat model of type 2 diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]

Phrase: "in which IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "identified as a diabetes susceptibility gene,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0919453:Susceptibility Gene [Gene or Genome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0017337:Gene [Gene or Genome]
   753   C0205396:Identified [Qualitative Concept]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "the recently described IDE-null mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   801   C0206745:Null Mouse [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "impaired glucose metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.31: In both models, cellular insulin-degrading activity has been found to be impaired. 

Phrase: "In both models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "cellular insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   875   C1145751:insulin activity [Molecular Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1561536:*Activity [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "impaired."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.32: Therefore, it is possible that in diabetes, IDE dysfunction also results in impaired amylin degradation, increased amylin aggregation, and, eventually, islet amyloid deposition. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that in diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "IDE dysfunction also"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0031847:dysfunction [Functional Concept]
   804   C0277785:Dysfunction, NOS [Qualitative Concept]
   748 E C0231174:Malfunction [Functional Concept]
   748 E C1881681:MALFUNCTION [Phenomenon or Process]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "results in impaired amylin degradation,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   760   C0221099:Impaired [Functional Concept]
   760   C0243125:degradation [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C0699900:Degradation [Organism Function]
   760   C1274040:Result [Functional Concept]
   760   C1415831:AMYLIN [Gene or Genome]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "increased amylin aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "eventually,"

Phrase: "islet amyloid deposition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0011560:Amyloid deposition [Pathologic Function]
   901   C1705760:Amyloid Deposition [Finding]
   827   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.33: The present study was performed to address the following questions: 1) Are amylin and insulin degraded in -cells by a common pathway? 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the following questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522634:Question [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Are"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "in -cells by a common pathway?"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.34: 2) Does inhibition of IDE alter amylin degradation and islet amyloid formation? and 3) Does IDE inhibition affect the cytotoxic properties of amylin toward -cells? 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "Does"

Phrase: "inhibition of IDE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0877008:enzyme inhibition [Disease or Syndrome]
   797   C1524081:Enzyme Inhibition [Physiologic Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "islet amyloid formation?"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "Does"

Phrase: "IDE inhibition"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0877008:enzyme inhibition [Disease or Syndrome]
   861   C1524081:Enzyme Inhibition [Physiologic Function]
   812   C0021467:Inhibition [Mental Process]
   812   C0021469:Inhibition [Molecular Function]
   812   C1628982:% inhibition [Quantitative Concept]
   812   C3463820:Inhibition [Activity]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   741 E C0311403:Inhibited [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the cytotoxic properties of amylin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "toward -cells?"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.35: To answer these questions, a pancreatic -cellderived cell line was used to characterize amylin degradation.  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "answer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706817:Answer [Intellectual Product]

Phrase: "these questions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522634:Question [Intellectual Product]

Phrase: "a pancreatic -cellderived cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "amylin degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.36: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Materials. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]
Processing 00000000.tx.37: Human and rat amylin were purchased from Bachem (Torrance, CA). 

Phrase: "Human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rat amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "were"

Phrase: "purchased from Bachem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Torrance,"

Phrase: "CA)."
Processing 00000000.tx.38: Human amylin radiolabeled with 125I at the COOH-terminal was purchased from Peninsula Labs (San Carlos, CA). 

Phrase: "Human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "radiolabeled with 125I"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1527121:Radiolabeled [Qualitative Concept]
   756 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "at the COOH-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "was"

Phrase: "purchased from Peninsula Labs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0587081:Labs [Finding]
   770   C0869011:purchased [Activity]
   737 E C0022877:Lab [Manufactured Object,Organization]

Phrase: "(San Carlos,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0445462:Carlos [Intellectual Product]

Phrase: "CA)."
Processing 00000000.tx.39: The 125I-insulin (mono-iodinated at the 14 position of the a-chain) and biosynthetic human insulin were provided by Lilly Research Laboratories. 

Phrase: "The 125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(mono-iodinated at the 14 position of the a-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1551432:Mono [Population Group]
   739   C1551969:Mono [Language]

Phrase: ")"

Phrase: "and"

Phrase: "biosynthetic human insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C0220781:Biosynthetic [Biologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "provided by Lilly Research Laboratories."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0022886:laboratories research [Research Activity]
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C1619828:Laboratories [Intellectual Product]
   760   C1999230:Provided [Activity]
   726 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.40: Bacitracin and Congo red were obtained from Sigma. 

Phrase: "Bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "and"

Phrase: "Congo red"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009742:Congo Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0009738:Congo [Geographic Area]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "were"

Phrase: "obtained from Sigma."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.41: The IDE-specific monoclonal antibody 9B12 (15) was kindly provided by Dr. 

Phrase: "The IDE-specific monoclonal antibody 9B12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C0021644:Insulin antibody [Immunologic Factor]

Phrase: "(15"

Phrase: ")"

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.42: Richard Roth (Stanford University, Stanford, CA). 

Phrase: "Richard Roth"

Phrase: "(Stanford University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "CA)."
Processing 00000000.tx.43: Preparation of amylin solutions. 

Phrase: "Preparation of amylin solutions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.44: Amylin solutions were prepared immediately before use from 1 mg/ml stock solutions into BSA-coated test tubes to prevent adhesion to plastic and minimize spontaneous amyloid fibril formation. 

Phrase: "Amylin solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "immediately before"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205548:Immediately [Temporal Concept]

Phrase: "use from 1 mg/ml stock solutions"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0439294:mg ml [Quantitative Concept]
   748   C0037633:Solutions [Substance]
   748   C0042153:use [Functional Concept]
   748   C0439269:mg% [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C0457083:Use [Functional Concept]
   748   C1710198:Stock [Idea or Concept]
   748   C1947944:Use [Intellectual Product]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   714 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "into BSA-coated test tubes to"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   840   C0183884:test tubes [Medical Device]
   804   C0022885:Test [Laboratory Procedure]
   804   C0039593:Test [Functional Concept]
   804   C0175730:tubes [Medical Device]
   804   C0392366:test [Intellectual Product]
   804   C1547937:Tubes [Intellectual Product]
   804   C1704474:Tubes [Quantitative Concept]
   771 E C1561954:tube [Conceptual Entity]
   771 E C1704730:TUBE [Medical Device]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "adhesion to plastic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001511:Adhesion [Pathologic Function]
   790   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "minimize"

Phrase: "spontaneous amyloid fibril formation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C3544412:amyloid fibril formation [Molecular Function]
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]
Processing 00000000.tx.45: Because of variable amounts of contaminating low-molecular-weight fragments and 125I-labeled albumin, the 125I-amylin was further purified by adsorption to a C18 Sep-Pak (Waters, Milford, MA) and eluted with 0.1% trifluoroacetic acid in acetonitrile. 

Phrase: "Because of variable amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of contaminating low-molecular-weight fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "125I-labeled albumin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the 125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "purified by adsorption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001674:Adsorption [Laboratory Procedure]
   790   C1998793:Purified [Functional Concept]

Phrase: "to a C18 Sep-Pak (Waters,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0043047:Waters [Inorganic Chemical,Pharmacologic Substance]
   779 E C0599638:WATER [Substance]
   779 E C1550678:Water [Inorganic Chemical]
   729 E C0443350:Watery [Qualitative Concept]

Phrase: "Milford,"

Phrase: "MA)"

Phrase: "and"

Phrase: "eluted with 0.1% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "in acetonitrile."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]
Processing 00000000.tx.46: The eluent was lyophilized and resuspended in the original buffer (0.1 mol/l sodium phosphate [pH 7.4] containing 0.05 mol/l NaCl, 0.1% NaN3, and 0.1% BSA) and frozen in aliquots until used. 

Phrase: "The eluent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "lyophilized"

Phrase: "and"

Phrase: "resuspended in the original buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0205313:Original [Idea or Concept]
   760   C2347409:Original [Occupational Activity]

Phrase: "(0.1 mol/l sodium phosphate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   799   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   799   C0031701:phosphate [Organophosphorus Compound]
   799   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   799   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   799   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "[pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "]"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.05 mol/l NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1% NaN3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0074721:NaN3 [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "0.1% BSA)"

Phrase: "and"

Phrase: "frozen in aliquots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016701:Frozen [Natural Phenomenon or Process]
   790   C0677542:Frozen [Functional Concept]
   756   C1510844:Aliquot [Quantitative Concept]

Phrase: "until"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.47: Cell culture. 

Phrase: "Cell culture."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.48: Rat insulinoma (RIN-m5F) cells (16) were purchased from American Type Culture Collection and maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum, 1.5 g/l sodium bicarbonate, 2.0 g/l glucose, 1 mmol/l L-glutamine, and 10 g/ml gentamicin. 

Phrase: "Rat insulinoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021670:insulinoma [Neoplastic Process]

Phrase: "(RIN-m5F"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "were"

Phrase: "purchased from American Type Culture Collection"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0598079:American Type Culture Collection [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0596070:American [Population Group]
   753   C0869011:purchased [Activity]
   753   C1516698:Collection [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1704814:Collection [Idea or Concept]
   753   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "maintained in RPMI-1640 medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C0024501:Maintain [Activity]

Phrase: "supplemented with 10% fetal bovine serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "1.5 g/l sodium bicarbonate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0074722:Sodium Bicarbonate [Organic Chemical,Pharmacologic Substance]
   799   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   799   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   799   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0973231:Bicarbonate [Inorganic Chemical]
   799   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "2.0 g/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "1 mmol/l L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "10 g/ml gentamicin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017436:Gentamicin [Antibiotic,Carbohydrate]
   812   C0546866:Gentamicin [Antibiotic,Carbohydrate]
Processing 00000000.tx.49: For experiments, cells were subcultured into 24-well plates at 2.5 x 105 cells/well; 

Phrase: "For experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subcultured into 24-well"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0200940:Subculture [Laboratory Procedure]
   737   C0699799:subculture [Population Group]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "at 2.5 x 105 cells/well"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   818   C2347578:Cells/well [Quantitative Concept]
   795   C0007634:Cells [Cell]
   795   C0205170:Well [Qualitative Concept]
   795   C1516077:At [Spatial Concept]
   795   C3146287:Well [Manufactured Object]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.50: the medium was changed every 2 days until used. 

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "every 2 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "until"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.51: Cellular degradation of amylin and insulin. 

Phrase: "Cellular degradation of amylin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1523935:cellular degradation [Cell Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.52: The degradation of amylin and insulin in RIN-m5F cells was determined by the trichloroacetic acid (TCA) solubility assay using a variation of a method previously described (17). 

Phrase: "The degradation of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "insulin in RIN-m5F cells"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   781   C0030281:Insulin Cell [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "determined by the trichloroacetic acid (TCA) solubility assay"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0037628:Solubility [Qualitative Concept]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a variation of a method previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.53: Briefly, RIN-m5F cells in 24-well plates were changed into serum-free medium containing 0.1% BSA for 1 h. 

Phrase: "Briefly,"

Phrase: "RIN-m5F cells in 24-well"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C2347578:Cells/well [Quantitative Concept]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "changed into serum-free medium"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   760   C0009458:Medium [Intellectual Product]
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C0392747:Changed [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C0443172:Changed [Quantitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1705217:Medium [Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   760   C3244283:medium [Intellectual Product]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% BSA for 1 h."
Processing 00000000.tx.54: The medium was removed and 125I-amylin or 125I-labeled insulin in serum-free medium containing 0.1% BSA was then added (20,000 cpm/ml), and the cells were incubated at 37C for the times indicated. 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "or"

Phrase: "125I-labeled insulin in serum-free medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0428357:Insulin - serum [Laboratory Procedure]
   774   C0487017:Insulin.free [Clinical Attribute]
   774   C0523720:free insulin [Laboratory Procedure]
   774   C1261415:insulin serum [Laboratory or Test Result]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% BSA"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "(20,000 cpm/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for the times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.55: In some experiments, bacitracin was included at 1 mg/ml. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "was"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "at 1 mg/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.56: The medium was removed and brought to 0.2% BSA and 16% TCA, chilled for 10 min on ice, and centrifuged at 3,000g for 15 min. 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "brought to 0.2% BSA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332302:brought [Functional Concept]

Phrase: "and"

Phrase: "16% TCA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "chilled for 10 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   737   C0085593:Chill [Sign or Symptom]

Phrase: "on ice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "and"

Phrase: "centrifuged at 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 15 min."
Processing 00000000.tx.57: The radioactivity in the supernatants and pellets was counted, and the degrading activity was expressed as the percent TCA soluble counts. 

Phrase: "The radioactivity in the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "the degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "expressed as the percent TCA soluble counts."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0439157:counts [Quantitative Concept]
   744   C0439165:Percent [Quantitative Concept]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   711 E C0750480:Count [Activity]
   711 E C1705566:Count [Quantitative Concept]
Processing 00000000.tx.58: In addition, the conditioned medium from the cells was removed and aliquots were tested for degrading activity by TCA solubility, as described above. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the conditioned medium from the cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "tested for degrading activity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0205177:Activity [Functional Concept]
   770   C0392366:tested [Intellectual Product]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "by TCA solubility,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037628:Solubility [Qualitative Concept]
   755 E C1749467:soluble [Cell Component]
   755 E C1948047:Soluble [Qualitative Concept]
   734   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "described above."
Processing 00000000.tx.59: Immunodetection of IDE. 

Phrase: "Immunodetection of IDE."
Processing 00000000.tx.60: Lysates were prepared from RIN-m5F cells in lysis buffer (50 mmol/l Tris [pH 7.4] containing 0.15 mol/l NaCl, 1% Triton X-100, and 0.1 mmol/l phenylmethylsulfonyl fluoride). 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "prepared from RIN-m5F cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C1419388:RIN [Gene or Genome]
   760   C1882531:RIN [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1521827:Prepare [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(50 mmol/l Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   812   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   812   C0814229:TRI [Intellectual Product]

Phrase: "[pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "]"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.15 mol/l NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "0.1 mmol/l phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   799   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.61: Aliquots of 10 g total protein were resolved in 7.5% SDS-PAGE then transferred to polyvinylidine fluoride membranes. 

Phrase: "Aliquots of 10 g total protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "resolved in 7.5% SDS-PAGE then"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   774   C1538570:PAGE-5 [Gene or Genome]
   748   C1514893:Resolved [Idea or Concept]
   748   C1704732:Page [Intellectual Product]
   748   C1883708:Then [Temporal Concept]
   748   C2699488:Resolved [Conceptual Entity]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to polyvinylidine fluoride membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   729 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.62: For immunodetection, the membranes were probed with the 9B12 monoclonal antibody directed against IDE at 1:1,000 dilution for 1 h at room temperature. 

Phrase: "For immunodetection,"

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "probed with the 9B12 monoclonal antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "directed against IDE at 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: ":"

Phrase: "1,000 dilution for 1 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1948037:Dilution [Functional Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.63: After being probed with a peroxidase-conjugated goat anti-mouse IgG (Jackson Immunochemicals, Temecula, CA) at 1:5,000 dilution for 1 h, immunoreactive proteins were detected by chemiluminescence. 

Phrase: "After"

Phrase: "being"

Phrase: "probed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0182400:Probe [Medical Device]
   966   C1704681:Probe [Gene or Genome]
   966   C2347609:Probe [Chemical Viewed Functionally]
   966   C3536729:Probe [Manufactured Object]

Phrase: "with a peroxidase-conjugated goat anti-mouse IgG (Jackson Immunochemicals,"

Phrase: "Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "CA) at 1"

Phrase: ":"

Phrase: "5,000 dilution for 1 h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1948037:Dilution [Functional Concept]

Phrase: "immunoreactive proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected by chemiluminescence."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   790   C0442726:Detected [Finding]
   790   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.64: Amyloid formation in RIN-m5F cultures. 

Phrase: "Amyloid formation in RIN-m5F cultures."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
Processing 00000000.tx.65: RIN-m5F cells were seeded onto poly-L-lysine-coated eight-well glass chamber slides at 105 cells/cm2. 

Phrase: "RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded onto poly-L-lysine-coated eight-well glass chamber"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   739   C0017596:Glass [Manufactured Object]
   739   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205170:Well [Qualitative Concept]
   739   C0205454:Eight [Quantitative Concept]
   739   C0747726:POLY [Conceptual Entity]
   739   C0935616:Chamber [Body Part, Organ, or Organ Component]
   739   C1522408:Coated [Qualitative Concept]
   739   C1947936:Glass [Medical Device]
   739   C3146287:Well [Manufactured Object]
   706   C0036563:Seed [Plant]
   706 E C0453946:Coat [Manufactured Object]
   706   C1705192:Seed [Laboratory Procedure]
   706   C1882540:{Seed} [Quantitative Concept]
   706   C2346495:Seed [Conceptual Entity]
   706 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "slides at 105 cells/cm2."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0439479:cm2 [Quantitative Concept]
   760   C0444330:Slide [Research Device]
   760   C0555206:CM2 [Congenital Abnormality]
   760   C1705201:Slide [Manufactured Object]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.66: The medium was changed to serum-free RPMI-1640 containing 0.1% BSA before treatment, then cells were treated with human amylin (0.011.0 mol/l) for 48 h. 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed to serum-free RPMI-1640"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0229671:Serum [Body Substance]
   753   C0332296:free [Functional Concept]
   753   C0392747:Changed [Functional Concept]
   753   C0443172:Changed [Quantitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% BSA before treatment,"

Phrase: "then cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with human amylin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0086418:Human [Human]
   770   C1415831:AMYLIN [Gene or Genome]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(0.011.0 mol/l) for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C2827807:h*mol/L [Quantitative Concept]
   793   C2827890:mol/L/h [Quantitative Concept]
   770   C0347982:mol/L [Quantitative Concept]
   767   C2346686:h l [Quantitative Concept]
Processing 00000000.tx.67: In some experiments, bacitracin was included at 1 mg/ml. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "was"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "at 1 mg/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.68: To determine the involvement of IDE-like proteolytic activity in islet amyloid formation, some cells were also treated with the IDE inhibitor bacitracin (1 mg/ml) at the same time as the amylin addition. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the involvement of IDE-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "like proteolytic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C0597304:Proteolytic [Molecular Function]
   861   C1561536:*Activity [Idea or Concept]
   861   C1947941:proteolytic [Enzyme]

Phrase: "in islet amyloid formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "some cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "treated with the IDE inhibitor bacitracin"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   800   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   770   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   767   C0021643:insulin inhibitor [Pharmacologic Substance]
   744   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1522326:Treated [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1999216:Inhibitor [Qualitative Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "(1 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml) at the same time"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "as the amylin addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.69: After treatment, the cells were washed with PBS, fixed for 5 min in 4% buffered formalin, and then stained for amyloid using a modified Congo red staining procedure (18). 

Phrase: "After treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with PBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "fixed for 5 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in 4% buffered formalin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stained for amyloid"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a modified Congo red staining procedure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   804   C1948041:Procedure [Therapeutic or Preventive Procedure]
   804   C2700391:Procedure [Activity]
   804   C3274430:PROCEDURE [Health Care Activity]
   804   C3538935:Procedure [Idea or Concept]
   804   C3539779:Procedure [Intellectual Product]
   717   C0009742:congo red staining [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   717   C1293958:congo red staining [Laboratory Procedure]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.70: Briefly, the samples were counterstained with Weigert iron hematoxylin for 15 s, rinsed, then placed in 0.5% HCl in 70% ethanol for 5 s. 

Phrase: "Briefly,"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "counterstained with Weigert iron hematoxylin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0491965:HEMATOXYLIN, IRON, WEIGERT'S [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   797   C0491950:HEMATOXYLIN WEIGERT'S [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]

Phrase: "for 15 s,"

Phrase: "rinsed,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "placed in 0.5% HCl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0444499:0/5 [Quantitative Concept]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "in 70% ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1381542:70% Ethanol [Clinical Drug]
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "for 5 s."
Processing 00000000.tx.71: After being washed, the samples were stained with Congo red for 20 min. 

Phrase: "After"

Phrase: "being"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "stained with Congo red"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   865   C0009742:Congo red stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Congo Red
   770   C0009738:Congo [Geographic Area]
   770   C0332575:Red [Finding]
   770   C1260956:Red [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "for 20 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.72: The samples were immediately dehydrated to xylene and mounted. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "dehydrated to xylene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011175:Dehydrated [Disease or Syndrome]
   790   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "mounted."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449878:mounted [Finding]
   966 E C0181909:Mount [Medical Device]
Processing 00000000.tx.73: The degree of amyloid formation was determined by fluorescence microscopy using a tetramethyl rhodamine isothiocyanate filter set. 

Phrase: "The degree of amyloid formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "was"

Phrase: "determined by fluorescence microscopy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a tetramethyl rhodamine isothiocyanate filter set."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0036849:Set [Mental Process]
   804   C1442518:Set [Functional Concept]
   804   C1705195:Set [Conceptual Entity]
   717   C0076308:tetramethylrhodamine isothiocyanate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.74: Cell toxicity assessment. 

Phrase: "Cell toxicity assessment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1261322:Assessment [Health Care Activity]
   827   C1516048:Assessment [Activity]
Processing 00000000.tx.75: For cell toxicity studies, RIN-m5F cells were cultured in 96-well plates and treated with human or rat amylin, without and with bacitracin as described above for 48 h. 

Phrase: "For cell toxicity studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in 96-well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "treated with human or rat amylin,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   753   C0086418:Human [Human]
   753   C1415831:AMYLIN [Gene or Genome]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "without"

Phrase: "and with bacitracin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   790   C1515981:And [Idea or Concept]
   734 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "as described above"

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.76: Cell viability was measured by the reduction of methylthiazolyldiphenyl-tetrazolium bromide (MTT), as previously described (19). 

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured by the reduction of methylthiazolyldiphenyl-tetrazolium bromide (MTT),"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0006222:Bromide [Inorganic Chemical]
   744   C0039704:tetrazolium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C0444706:Measured [Qualitative Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.77: Statistics. 

Phrase: "Statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.78: All data are expressed as means  SE. 

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as means  SE."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.79: For degradation assays, comparisons for differences between groups were made by one-way ANOVA with Dunnetts posttest (degradation assays) or two-way ANOVA with Bonferroni posttest (viability assay). 

Phrase: "For degradation assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "comparisons for differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707455:Comparison [Activity]

Phrase: "between groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "made by one-way ANOVA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C1709320:One-way ANOVA [Quantitative Concept]
   760   C0205447:One [Quantitative Concept]
   726   C1881534:Make [Functional Concept]

Phrase: "with Dunnetts posttest"

Phrase: "(degradation assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: ")"

Phrase: "or"

Phrase: "two-way ANOVA with Bonferroni posttest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1710497:Two-way ANOVA [Quantitative Concept]
   753   C0205448:Two [Quantitative Concept]

Phrase: "(viability assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.80: P < 0.05 was interpreted as significant. 

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "was"

Phrase: "interpreted as significant."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0237881:significant [Quantitative Concept]
   790   C0750502:Significant [Idea or Concept]
   790   C1285553:interpreted [Functional Concept]
   790   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.81: Analyses were made using the GraphPad Prism3 software package.  

Phrase: "Analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the GraphPad Prism3 software package."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013194:Package [Medical Device]
   812   C2700580:Package [Manufactured Object]
Processing 00000000.tx.82: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Amylin and insulin degradation by RIN-m5F cells was examined over time. 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin degradation by RIN-m5F cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "examined over time."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0040223:Time [Temporal Concept]
   790   C0332128:Examined [Finding]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.83: The amount of degradation was limited to 20% to remain within the linear range of the assay. 

Phrase: "The amount of degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "limited to 20% to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439801:Limited [Functional Concept]
   770   C3542948:Limited [Intellectual Product]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "remain within the linear range of the assay."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0005507:Assay [Laboratory Procedure]
   744   C0205132:Linear [Spatial Concept]
   744   C0243073:assay [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]
Processing 00000000.tx.84: Degradation of 125I-amylin reached 20% by 30 min (Fig. 1). 

Phrase: "Degradation of 125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "20% by 30 min (Fig. 1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   783   C1301862:Min 1 [Temporal Concept]
   753   C0349966:Fig [Food]
   753   C0702093:/min [Temporal Concept]
   753   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.85: In contrast, 125I-insulin degraded much more slowly, and required 120 min of incubation to reach 20% degradation (Fig. 2). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "much more slowly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439834:Slowly [Qualitative Concept]

Phrase: "and"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "120 min of incubation to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "20% degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.86: The addition of either unlabeled amylin or insulin to the reaction decreased the degradation of both substrates, indicating a common degradative pathway. 

Phrase: "The addition of either unlabeled amylin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "or"

Phrase: "insulin to the reaction"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C1527401:Insulin Reaction [Disease or Syndrome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the degradation of both substrates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "indicating"

Phrase: "a common degradative pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1511758:Degradative Pathway [Conceptual Entity]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.87: The addition of the IDE inhibitor bacitracin essentially eliminated the degradation of amylin and insulin by the cells. 

Phrase: "The addition of the IDE inhibitor bacitracin essentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1883712:Addition [Functional Concept]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "the degradation of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "insulin by the cells."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   802   C0030281:Insulin Cell [Cell]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.88: There was no detectable amylin- or insulin-degrading activity in the conditioned medium (data not shown), suggesting that degradation was caused by uptake and intracellular degradation. 

Phrase: "There"

Phrase: "was"

Phrase: "no detectable amylin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "or"

Phrase: "insulin-degrading activity in the conditioned medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C1145751:insulin activity [Molecular Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1561536:*Activity [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]
   738   C1292728:Condition activity [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "caused by uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0243144:Uptake [Physiologic Function]
   790   C0347980:% uptake [Quantitative Concept]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "intracellular degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.89: The presence of IDE was readily detected in the cells by an immunoreactive band at 110 kDa (Fig. 2). 

Phrase: "The presence of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "readily"

Phrase: "detected in the cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by an immunoreactive band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "at 110 kDa (Fig. 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]
   812   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.90: Therefore, RIN-m5F cells possess mechanisms to internalize and degrade both insulin and amylin and to express IDE. 

Phrase: "Therefore,"

Phrase: "RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "mechanisms to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "internalize"

Phrase: "and"

Phrase: "degrade"

Phrase: "both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.91: View larger version (22K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.92: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.93: Amylin degradation in RIN-m5F cells over time. 

Phrase: "Amylin degradation in RIN-m5F cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "over time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.94: The degradation of amylin by RIN-m5F cells over time was measured by the production of acid-soluble products from 125I-amylin in cell culture media. 

Phrase: "The degradation of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "by RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "measured by the production of acid-soluble products"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   744   C0001128:Acid [Chemical]
   744   C0033268:production [Occupational Activity]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0444706:Measured [Qualitative Concept]
   744   C1514468:Products [Entity]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "from 125I-amylin in cell culture media."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   861   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   827   C0007585:Cell Culture [Laboratory Procedure]
   827   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   799   C0009458:Media [Intellectual Product]
   799   C0010453:Culture [Idea or Concept]
   799   C0162867:Media [Tissue]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C1254021:Media [Tissue]
   799   C2242979:Culture [Laboratory Procedure]
   766 E C0439536:Medium [Quantitative Concept]
   766 E C1705217:Medium [Substance]
   766 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.95: Cells were also treated with 0.1 mol/l unlabeled amylin or insulin or the IDE inhibitor bacitracin (1 mg/ml). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "treated with 0.1 mol/l unlabeled amylin"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0347982:mol/L [Quantitative Concept]
   744   C0027960:Mole [Neoplastic Process]
   744   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   744   C0324740:Mole [Mammal]
   744   C0439189:Mole [Quantitative Concept]
   744   C1415831:AMYLIN [Gene or Genome]
   744   C1456781:mole [Neoplastic Process]
   744   C1522326:Treated [Functional Concept]
   744   C1824986:mol [Gene or Genome]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "the IDE inhibitor bacitracin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   708   C0021643:insulin inhibitor [Pharmacologic Substance]

Phrase: "(1 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.96: Data are expressed as percent acid-soluble products produced (n = 3). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as percent acid-soluble products"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0439165:Percent [Quantitative Concept]
   753   C1514468:Products [Entity]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "produced"

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.97: , no treatment; 

Phrase: ","

Phrase: "no treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: ";"
Processing 00000000.tx.98: , + amylin; 

Phrase: ", + amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.99: , + insulin; 

Phrase: ", + insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.100: , + bacitracin.  

Phrase: ", + bacitracin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
Processing 00000000.tx.101: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.102: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.103: Insulin degradation in RIN-m5F cells over time. 

Phrase: "Insulin degradation in RIN-m5F cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "over time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.104: A: The degradation of insulin by RIN-m5F cells over time was measured by the production of acid-soluble products from 125I-insulin in cell culture media. 

Phrase: "A"

Phrase: ":"

Phrase: "The degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "by RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "measured by the production of acid-soluble products"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   744   C0001128:Acid [Chemical]
   744   C0033268:production [Occupational Activity]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0444706:Measured [Qualitative Concept]
   744   C1514468:Products [Entity]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "from 125I-insulin in cell culture media."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   861   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   827   C0007585:Cell Culture [Laboratory Procedure]
   827   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   799   C0009458:Media [Intellectual Product]
   799   C0010453:Culture [Idea or Concept]
   799   C0162867:Media [Tissue]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C1254021:Media [Tissue]
   799   C2242979:Culture [Laboratory Procedure]
   766 E C0439536:Medium [Quantitative Concept]
   766 E C1705217:Medium [Substance]
   766 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.105: Cells were also treated with 0.1 mol/l unlabeled amylin or insulin or the IDE inhibitor bacitracin (1 mg/ml). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "treated with 0.1 mol/l unlabeled amylin"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0347982:mol/L [Quantitative Concept]
   744   C0027960:Mole [Neoplastic Process]
   744   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   744   C0324740:Mole [Mammal]
   744   C0439189:Mole [Quantitative Concept]
   744   C1415831:AMYLIN [Gene or Genome]
   744   C1456781:mole [Neoplastic Process]
   744   C1522326:Treated [Functional Concept]
   744   C1824986:mol [Gene or Genome]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "the IDE inhibitor bacitracin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   708   C0021643:insulin inhibitor [Pharmacologic Substance]

Phrase: "(1 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.106: Data are expressed as percent acid-soluble products produced (n = 3). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as percent acid-soluble products"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0439165:Percent [Quantitative Concept]
   753   C1514468:Products [Entity]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "produced"

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.107: , no treatment; 

Phrase: ","

Phrase: "no treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: ";"
Processing 00000000.tx.108: , + amylin; 

Phrase: ", + amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.109: , + insulin; 

Phrase: ", + insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.110: , + bacitracin. 

Phrase: ", + bacitracin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
Processing 00000000.tx.111: B: Lysates from RIN-m5F were probed with the IDE-specific monoclonal antibody 9B12, and immunoreactive proteins were detected by chemiluminescence. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Lysates from RIN-m5F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "probed with the IDE-specific monoclonal antibody 9B12,"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   782   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0021644:Insulin antibody [Immunologic Factor]
   757   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0205369:Specific [Qualitative Concept]
   739   C0746619:monoclonal [Finding]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1552740:specific [Intellectual Product]
   739   C1579433:Insulin [Pharmacologic Substance]
   706   C0182400:Probe [Medical Device]
   706   C1704681:Probe [Gene or Genome]
   706   C2347609:Probe [Chemical Viewed Functionally]
   706   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "immunoreactive proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected by chemiluminescence."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   790   C0442726:Detected [Finding]
   790   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.112: A single band at 110 kDa was detected, consistent with the presence of IDE.  

Phrase: "A single band at 110 kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0230715:A band [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "consistent with the presence of IDE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.113: To further characterize amylin and insulin degradation in RIN-m5F cells, the degradation was measured with increasing dosages of unlabeled competitor. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "characterize"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin degradation in RIN-m5F cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "the degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "measured with increasing dosages of unlabeled competitor."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0178602:Dosages [Quantitative Concept]
   748   C0442808:Increasing [Functional Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.114: The degradation of 125I-amylin was decreased in a dosage-dependent manner by either unlabeled insulin or amylin (Fig. 3). 

Phrase: "The degradation of 125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "decreased in a dosage-dependent manner"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0178602:Dosage [Quantitative Concept]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "by either unlabeled insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.115: At all concentrations, unlabeled insulin was a more effective inhibitor than amylin. 

Phrase: "At all concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "unlabeled insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "a more effective inhibitor than amylin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.116: Similarly, the degradation of 125I-insulin was inhibited by both amylin and insulin (Fig. 4), with insulin generally the more effective inhibitor. 

Phrase: "Similarly,"

Phrase: "the degradation of 125I-insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C3547574:insulin degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "inhibited by both amylin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "with insulin generally"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the more effective inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.117: These observations were consistent with previously determined enzymatic properties of IDE, in which insulin had a three- to sixfold higher affinity for purified IDE than amylin (13). 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "were"

Phrase: "consistent with previously"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "determined"

Phrase: "enzymatic properties of IDE,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "in which insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "had"

Phrase: "a three-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "to sixfold higher affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for purified IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "than amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.118: Two possible complications of the cell culture system are the potential for direct interaction between human amylin and insulin (20) and membrane perturbations that may impede receptor-mediated uptake of substrates (3). 

Phrase: "Two possible complications of the cell culture system"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0009566:Complications [Pathologic Function]
   744   C1171258:complications [Pathologic Function]
   711 E C2362589:Complication [Idea or Concept]

Phrase: "are"

Phrase: "the potential for direct interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245505:Potential [Qualitative Concept]

Phrase: "between human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(20"

Phrase: ")"

Phrase: "and"

Phrase: "membrane perturbations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332453:perturbation [Functional Concept]

Phrase: "that"

Phrase: "may"

Phrase: "impede"

Phrase: "receptor-mediated uptake of substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.119: Rat amylin is also an IDE substrate (13), but it does not interact with insulin or cause membrane disruption. 

Phrase: "Rat amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "an IDE substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0178623:enzyme substrate [Chemical Viewed Functionally]
   812   C1710236:Substrate [Manufactured Object]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "it"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "cause membrane disruption."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.120: Rat amylin (100 nmol/l) inhibited insulin degradation to 49.7  1.2% of baseline insulin degradation, a result similar to that found with human amylin, indicating that reciprocal inhibition of amylin and insulin degradation is attributable to a common pathway of proteolysis. 

Phrase: "Rat amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "(100 nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439191:NMOLE [Quantitative Concept]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "insulin degradation to 49.7  1.2%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "of baseline insulin degradation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C3547574:insulin degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "found with human amylin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0086418:Human [Human]
   770   C0150312:Found [Quantitative Concept]
   770   C1415831:AMYLIN [Gene or Genome]
   737 E C0243095:Find [Finding]

Phrase: "indicating"

Phrase: "that reciprocal inhibition of amylin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0683266:Reciprocal inhibition [Therapeutic or Preventive Procedure]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C1882911:Reciprocal [Qualitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "attributable to a common pathway of proteolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596130:Attributable [Mental Process]
Processing 00000000.tx.121: View larger version (38K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.122: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.123: Amylin degradation in RIN-m5F cells. 

Phrase: "Amylin degradation in RIN-m5F cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.124: The degradation of amylin by RIN-m5F cells was measured by the production of acid-soluble products from 125I-amylin in cell culture media. 

Phrase: "The degradation of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "by RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured by the production of acid-soluble products"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   744   C0001128:Acid [Chemical]
   744   C0033268:production [Occupational Activity]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0444706:Measured [Qualitative Concept]
   744   C1514468:Products [Entity]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "from 125I-amylin in cell culture media."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   861   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   827   C0007585:Cell Culture [Laboratory Procedure]
   827   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   799   C0009458:Media [Intellectual Product]
   799   C0010453:Culture [Idea or Concept]
   799   C0162867:Media [Tissue]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C1254021:Media [Tissue]
   799   C2242979:Culture [Laboratory Procedure]
   766 E C0439536:Medium [Quantitative Concept]
   766 E C1705217:Medium [Substance]
   766 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.125: Cells were also treated with the indicated concentrations (nmol/l) of unlabeled amylin or unlabeled insulin. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "treated with the indicated concentrations"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0086045:Concentrations [Mental Process]
   760   C1444656:Indicated [Finding]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "(nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439191:NMOLE [Quantitative Concept]

Phrase: "l) of unlabeled amylin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439394:l's [Quantitative Concept]
   770   C1706495:L- [Intellectual Product]
   770   C3642217:/L [Quantitative Concept]

Phrase: "or"

Phrase: "unlabeled insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.126: Data are expressed as percent acid-soluble products produced (n = 6). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as percent acid-soluble products"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0439165:Percent [Quantitative Concept]
   753   C1514468:Products [Entity]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "produced"

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.127: *P < 0.05, **P < 0.001.  

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "*"

Phrase: "*P < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.128: View larger version (37K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 4. 

Phrase: "4."
Processing 00000000.tx.130: Insulin degradation in RIN-m5F cells. 

Phrase: "Insulin degradation in RIN-m5F cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.131: The degradation of insulin by RIN-m5F cells was measured by the production of acid-soluble products from 125I-amylin in cell culture media. 

Phrase: "The degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "by RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured by the production of acid-soluble products"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   744   C0001128:Acid [Chemical]
   744   C0033268:production [Occupational Activity]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0444706:Measured [Qualitative Concept]
   744   C1514468:Products [Entity]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "from 125I-amylin in cell culture media."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   861   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   827   C0007585:Cell Culture [Laboratory Procedure]
   827   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   799   C0009458:Media [Intellectual Product]
   799   C0010453:Culture [Idea or Concept]
   799   C0162867:Media [Tissue]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C1254021:Media [Tissue]
   799   C2242979:Culture [Laboratory Procedure]
   766 E C0439536:Medium [Quantitative Concept]
   766 E C1705217:Medium [Substance]
   766 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.132: Cells were also treated with the indicated concentrations (nmol/l) of unlabeled amylin or unlabeled insulin. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "treated with the indicated concentrations"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0086045:Concentrations [Mental Process]
   760   C1444656:Indicated [Finding]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "(nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439191:NMOLE [Quantitative Concept]

Phrase: "l) of unlabeled amylin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439394:l's [Quantitative Concept]
   770   C1706495:L- [Intellectual Product]
   770   C3642217:/L [Quantitative Concept]

Phrase: "or"

Phrase: "unlabeled insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.133: Data are expressed as percent acid-soluble products produced (n = 6). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as percent acid-soluble products"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0439165:Percent [Quantitative Concept]
   753   C1514468:Products [Entity]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "produced"

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.134: **P < 0.001.  

Phrase: "*"

Phrase: "*P < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.135: Because amylin is produced by healthy individuals without the formation of islet amyloid, a mechanism must be in place to prevent amylin aggregation under normal conditions. 

Phrase: "Because"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "is"

Phrase: "produced by healthy individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "without the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of islet amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "must"

Phrase: "be in place to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0442504:Place [Spatial Concept]
   770   C1704765:Place [Functional Concept]
   770   C1882509:Place [Activity]
   770   C2987476:Be [Conceptual Entity]
   770   C3496241:place [Disease or Syndrome]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "amylin aggregation under normal conditions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.136: To examine whether cellular degradation by IDE may contribute to this protective process, a cell culture system to study islet amyloid formation was developed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "cellular degradation by IDE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1523935:cellular degradation [Cell Function]
   783   C0678637:enzyme degradation [Laboratory Procedure]
   783   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "may"

Phrase: "contribute to this protective process,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]
   760   C1880177:Contribute [Activity]

Phrase: "a cell culture system to"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   884   C1516329:Cell Culture System [Molecular Biology Research Technique]
   840   C0007585:Cell Culture [Laboratory Procedure]
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   804   C2242979:Culture [Laboratory Procedure]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "islet amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "developed."
Processing 00000000.tx.137: RIN-m5F cells were cultured on poly-L-lysine-coated glass chamber slides for 3 days of culture, then treated with human amylin (101,000 nmol/l) for 48 h. 

Phrase: "RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured on poly-L-lysine-coated glass chamber"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   744   C0017596:Glass [Manufactured Object]
   744   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0747726:POLY [Conceptual Entity]
   744   C0935616:Chamber [Body Part, Organ, or Organ Component]
   744   C1522408:Coated [Qualitative Concept]
   744   C1947936:Glass [Medical Device]
   711   C0010453:Culture [Idea or Concept]
   711   C0220814:culture [Functional Concept]
   711   C0430400:Culture [Laboratory Procedure]
   711 E C0453946:Coat [Manufactured Object]
   711   C2242979:Culture [Laboratory Procedure]
   711 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "slides for 3 days of culture,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439228:days [Temporal Concept]
   753   C0444330:Slide [Research Device]
   753   C1705201:Slide [Manufactured Object]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C0332173:/day [Temporal Concept]
   719 E C0439505:/day [Temporal Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with human amylin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0086418:Human [Human]
   770   C1415831:AMYLIN [Gene or Genome]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(101,000 nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439191:NMOLE [Quantitative Concept]

Phrase: "l) for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C2346686:L/h [Quantitative Concept]
   770   C0439394:l's [Quantitative Concept]
   770   C1706495:L- [Intellectual Product]
   770   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.138: Amyloid was detected by a modified Congo red fluorescence staining method (18), which includes an acidic iron hematoxylin counterstain that minimizes the intense autofluorescence seen using the original method (21). 

Phrase: "Amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected by a modified Congo red fluorescence staining method"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   796   C1293958:Congo red stain method [Laboratory Procedure]
           congo red staining
   784   C0009742:congo red staining [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Congo Red
   764   C0487602:Staining method [Laboratory Procedure]
           Staining
   762   C0205349:Modified By [Qualitative Concept]
   755   C1318786:Fluorescent stain method [Laboratory Procedure]
   742   C0009738:Congo [Geographic Area]
   742   C0016315:Fluorescence [Natural Phenomenon or Process]
   742   C0025663:Method [Intellectual Product]
   742   C0332575:Red [Finding]
   742   C0392747:Modified [Functional Concept]
   742   C0442726:Detected [Finding]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]
   742   C1260956:Red [Qualitative Concept]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1704680:Staining [Finding]
   712   C0303920:Fluorescent stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   708 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "an acidic iron hematoxylin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "counterstain"

Phrase: "that"

Phrase: "minimizes"

Phrase: "the intense autofluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0544711:Autofluorescence [Finding]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the original method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.139: Human amylin induced a dosage-dependent increase in staining, detectable at 100 nmol/l and pronounced at 1 mol/l (Fig. 5). 

Phrase: "Human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a dosage-dependent increase in staining,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "detectable at 100 nmol/l"

Phrase: "and"

Phrase: "pronounced"

Phrase: "at 1 mol/l (Fig. 5"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   827   C0347982:mol/L [Quantitative Concept]
   827   C1412113:AT-1 [Gene or Genome]
   799   C0027960:Mole [Neoplastic Process]
   799   C0324740:Mole [Mammal]
   799   C0349966:Fig [Food]
   799   C0439189:Mole [Quantitative Concept]
   799   C1337208:FIG [Food]
   799   C1456781:mole [Neoplastic Process]
   799   C1516077:At [Spatial Concept]
   799   C1824986:mol [Gene or Genome]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.140: This finding demonstrated that exogenous human amylin can form amyloid deposits in RIN-m5F cell cultures. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "demonstrated"

Phrase: "that exogenous human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1415831:AMYLIN [Gene or Genome]

Phrase: "can"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits in RIN-m5F cell cultures."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0007585:Cell Cultures [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0010453:Cultures [Idea or Concept]
   753   C0333562:Deposit [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1419388:RIN [Gene or Genome]
   753   C1704653:Cell [Medical Device]
   753   C1882531:RIN [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.141: When the cells were treated with the IDE inhibitor bacitracin, amyloid staining was markedly increased in intensity at all amylin concentrations compared with cells without bacitracin, including at the lowest amylin concentration (10 nmol/l). 

Phrase: "When"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with the IDE inhibitor bacitracin,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   800   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   770   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   767   C0021643:insulin inhibitor [Pharmacologic Substance]
   744   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1522326:Treated [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1999216:Inhibitor [Qualitative Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "amyloid staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "increased in intensity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C0522510:Intensity [Qualitative Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "at all amylin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "compared with cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1707455:Compared [Activity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "without bacitracin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "including at the lowest amylin concentration"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   753   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   753   C0086045:Concentration [Mental Process]
   753   C0332257:Including [Functional Concept]
   753   C1415831:AMYLIN [Gene or Genome]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1708760:Lowest [Qualitative Concept]
   719 E C0205251:low [Qualitative Concept]
   719 E C1299352:Low [Qualitative Concept]
   719 E C1550472:low [Idea or Concept]
   719 E C1552866:include [Idea or Concept]
   719 E C2700399:Include [Activity]

Phrase: "(10 nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439191:NMOLE [Quantitative Concept]

Phrase: "l)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.142: These findings suggest impairment of the cells ability to clear amylin by a protease with characteristics consistent with IDE. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "impairment of the cells ability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "amylin by a protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C1415831:AMYLIN [Gene or Genome]

Phrase: "with characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521970:Characteristics [Qualitative Concept]

Phrase: "consistent with IDE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.143: View larger version (75K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(75K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.145: Bacitracin increases amyloid deposition in RIN-m5F cells. 

Phrase: "Bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "amyloid deposition in RIN-m5F cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011560:Amyloid deposition [Pathologic Function]
   790   C1705760:Amyloid Deposition [Finding]
   753   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.146: RIN-m5F cells were treated with 0, 10, 100, or 1,000 nmol/l human amylin, as indicated. 

Phrase: "RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 0,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "10,"

Phrase: "100,"

Phrase: "or"

Phrase: "1,000 nmol/l human amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   799   C1415831:AMYLIN [Gene or Genome]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.147: Cells were cultured in the absence (left) or presence (right) of the IDE inhibitor bacitracin (Bac). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in the absence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "of the IDE inhibitor bacitracin (Bac)."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   708   C0021643:insulin inhibitor [Pharmacologic Substance]
Processing 00000000.tx.148: Deposition of islet amyloid was detected by Congo red fluorescence. 

Phrase: "Deposition of islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0011560:Amyloid deposition [Pathologic Function]
   819   C1705760:Amyloid Deposition [Finding]
   770   C0333562:Deposition [Functional Concept]

Phrase: "was"

Phrase: "detected by Congo red fluorescence."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0009742:Congo Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0009738:Congo [Geographic Area]
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0332575:Red [Finding]
   760   C0442726:Detected [Finding]
   760   C1260956:Red [Qualitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.149: Brightfield exposures of the same cells are shown in the insets. 

Phrase: "Brightfield exposures of the same cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0274281:exposures [Injury or Poisoning]
   753   C0728853:exposures [Phenomenon or Process]
   719 E C0332157:Exposure [Clinical Attribute]

Phrase: "are"

Phrase: "shown in the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "insets."
Processing 00000000.tx.150: Magnification x100.  

Phrase: "Magnification x100."
Processing 00000000.tx.151: Because amylin has been implicated in -cell toxicity, the effect of IDE inhibition on RIN-m5F cell viability was determined by MTT reduction (Fig. 6). 

Phrase: "Because"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "implicated"

Phrase: "in -cell toxicity,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]

Phrase: "the effect of IDE inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on RIN-m5F cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007620:Cell Viability [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0443348:viability [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined by MTT reduction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0006222:Bromide [Inorganic Chemical]
   753   C0039704:tetrazolium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.152: Treatment with human amylin for 48 h decreased cell viability in a dosage-dependent manner, peaking at 44% with 1,000 nmol/l amylin. 

Phrase: "Treatment with human amylin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "for 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "cell viability in a dosage-dependent manner,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0007620:Cell Viability [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0443348:viability [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "peaking at 44%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0444505:Peak [Quantitative Concept]

Phrase: "with 1,000 nmol/l amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   804   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.153: In the presence of bacitracin, the cell viability was markedly lower at all amylin concentrations, reaching the maximum reduction (68%) at only 10 nmol/l amylin. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of bacitracin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "the cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "markedly lower at all amylin concentrations,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "the maximum reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(68%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: "at only 10 nmol/l amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   804   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.154: Conversely, rat amylin had no effect on viability, whether with or without bacitracin. 

Phrase: "Conversely,"

Phrase: "rat amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "had"

Phrase: "no effect on viability,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "whether with"

Phrase: "or without bacitracin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   734 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
Processing 00000000.tx.155: Therefore, an IDE inhibitor increased the ability of amylin to reduce RIN-m5F cell viability. 

Phrase: "Therefore,"

Phrase: "an IDE inhibitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0021643:insulin inhibitor [Pharmacologic Substance]
   861   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   861   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   812   C1999216:Inhibitor [Qualitative Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the ability of amylin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "reduce"

Phrase: "RIN-m5F cell viability."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007620:Cell Viability [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0443348:viability [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.156: View larger version (24K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.157: 6. 

Phrase: "6."
Processing 00000000.tx.158: Bacitracin increases amylin-induced cytotoxicity. 

Phrase: "Bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "amylin-induced cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.159: RIN-m5F cells were treated with 0, 10, 100, or 1,000 nmol/l human amylin or 1,000 nmol/l rat amylin, as indicated. 

Phrase: "RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 0,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "10,"

Phrase: "100,"

Phrase: "or"

Phrase: "1,000 nmol/l human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   799   C1415831:AMYLIN [Gene or Genome]

Phrase: "or"

Phrase: "1,000 nmol/l rat amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   799   C1415831:AMYLIN [Gene or Genome]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.160: Cells were cultured in the absence () or presence () of the IDE inhibitor bacitracin. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in the absence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "of the IDE inhibitor bacitracin."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   708   C0021643:insulin inhibitor [Pharmacologic Substance]
Processing 00000000.tx.161: Cell toxicity was assessed by the degree of MTT reduction by the cells (n = 6). 

Phrase: "Cell toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "was"

Phrase: "assessed by the degree of MTT reduction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0006222:Bromide [Inorganic Chemical]
   742   C0039704:tetrazolium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]
   742   C0441889:Degree [Qualitative Concept]
   742   C0449286:Degree [Quantitative Concept]
   742   C0542560:Degree [Intellectual Product]
   742   C1516048:Assessed [Activity]
   742   C1561545:degree [Quantitative Concept]
   742   C2348088:Degree [Quantitative Concept]

Phrase: "by the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.162: *P < 0.01.   

Phrase: "*P < 0.01."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.163: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  A pathologic feature of type 2 diabetes is the presence of islet amyloid deposits composed predominantly of amylin (1). 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A pathologic feature of type 2 diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "is"

Phrase: "the presence of islet amyloid deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "composed"

Phrase: "predominantly of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   790   C1415831:AMYLIN [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.164: Whether islet amyloid is merely a marker of type 2 diabetes or actually contributes to the disease is a matter of some discussion. 

Phrase: "Whether"

Phrase: "islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "merely"

Phrase: "a marker of type 2 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0005516:Marker [Clinical Attribute]

Phrase: "or"

Phrase: "actually"

Phrase: "contributes to the disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0012634:Disease [Disease or Syndrome]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "a matter of some discussion."
Processing 00000000.tx.165: Several lines of evidence suggest an association between the presence of islet amyloid and diabetes and reduced -cell mass. 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an association between the presence of islet amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "reduced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "cell mass."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.166: In monkeys, the formation of islet amyloid correlates with early reduced insulin secretion and glucose intolerance, and, with time, correlates with greater deficiency in insulin secretion and glucose tolerance and ultimately hyperglycemia (22). 

Phrase: "In monkeys,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026447:Monkeys [Mammal]

Phrase: "the formation of islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "correlates with early reduced insulin secretion"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1256369:insulin secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0392756:Reduced [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucose intolerance,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0271650:Glucose Intolerance [Disease or Syndrome]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0231199:Intolerance [Organism Function]
   861   C1744706:intolerance [Intellectual Product]
   861   C2355652:Intolerance [Organism Attribute]
   789 E C0231200:Intolerant [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "with time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "correlates with greater deficiency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0011155:Deficiency [Functional Concept]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C0443228:greater [Quantitative Concept]
   770   C1623416:deficiency [Qualitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "in insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucose tolerance"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0178665:Glucose tolerance [Physiologic Function]
   861   C0013220:Tolerance [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0020963:Tolerance [Pathologic Function]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]

Phrase: "and"

Phrase: "ultimately hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.167: In humans, the degree of amyloid formation correlates with the severity of diabetes, as evidenced by the requirement for insulin replacement therapy (23,24). 

Phrase: "In humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "the degree of amyloid formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "correlates with the severity of diabetes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0439793:Severity [Qualitative Concept]
   753   C2983285:Severity [Intellectual Product]

Phrase: "as"

Phrase: "evidenced by the requirement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514873:Requirement [Functional Concept]
   737   C0332120:Evidence [Functional Concept]

Phrase: "for insulin replacement therapy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.168: Other evidence suggests that -cell death is caused by intermediate-sized fibrils that are precursors of islet amyloid (3,4). 

Phrase: "Other evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that -cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "caused by intermediate-sized fibrils"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0205103:Intermediate [Spatial Concept]
   760   C0225328:fibrils [Cell Component]
   760   C1550465:intermediate [Idea or Concept]
   760   C2827755:INTERMEDIATE [Laboratory or Test Result]
   726   C0015127:cause [Functional Concept]
   726   C0456389:size [Spatial Concept]
   726   C1524003:Cause [Conceptual Entity]
   726 E C1948066:Fibril [Physical Object]

Phrase: "that"

Phrase: "are"

Phrase: "precursors of islet amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1709634:Precursor [Idea or Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.169: In this case, islet amyloid deposits reflect an end-stage effect of amylin aggregation secondary to -cell death. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "islet amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936349:Amyloid Deposits [Acquired Abnormality]
   827   C0333562:Deposits [Functional Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "an end-stage effect of amylin aggregation secondary to -cell death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.170: The factors that prevent amylin fibril formation, -cell death, and islet amyloid deposition in the nondisease state are not understood. 

Phrase: "The factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "amylin fibril formation, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "islet amyloid deposition in the nondisease state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0011560:Amyloid deposition [Pathologic Function]
   778   C1705760:Amyloid Deposition [Finding]
   748   C0333562:Deposition [Functional Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.171: Because amylin is continually produced in nondiabetic humans with no amyloid formation, the mere presence of amylin is insufficient to cause fibril formation. 

Phrase: "Because"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "is"

Phrase: "continually"

Phrase: "produced in nondiabetic humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086418:Humans [Human]

Phrase: "with no amyloid formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "the mere presence of amylin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "insufficient to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205412:Insufficient [Qualitative Concept]
   861   C0231180:Insufficient [Qualitative Concept]
   789 E C0231179:Insufficiency [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "fibril formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.172: Indeed, transgenic animals overexpressing human amylin do not form amyloid deposits (57,25), confirming that elevated amylin levels alone are insufficient for amyloid formation. 

Phrase: "Indeed,"

Phrase: "transgenic animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003069:Animals, Transgenic [Animal]
   861   C0003062:Animals [Animal]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "(57,"

Phrase: "25"

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that elevated amylin levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "are"

Phrase: "insufficient for amyloid formation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205412:Insufficient [Qualitative Concept]
   770   C0231180:Insufficient [Qualitative Concept]
Processing 00000000.tx.173: However, when diabetic conditions are introduced, such as the ob mutation, growth hormone/steroid treatment, or a high-fat diet, these animals develop islet amyloid, islet dysfunction, reduced insulin secretion, and hyperglycemia (810). 

Phrase: "However,"

Phrase: "when"

Phrase: "diabetic conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "are"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: ","

Phrase: "such as the ob mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "growth hormone/steroid treatment,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0744483:growth hormone treatment [Disease or Syndrome]
   875   C0279025:hormone treatment [Therapeutic or Preventive Procedure]
   875   C2966671:Hormone treatment [Clinical Attribute]
   861   C0149783:steroid treatment [Therapeutic or Preventive Procedure]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "a high-fat diet,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "develop"

Phrase: "islet amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "islet dysfunction,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "reduced insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "(810"

Phrase: ")."
Processing 00000000.tx.174: Therefore, in type 2 diabetes, the balance shifts from amylin clearance to deposition, either by increased amounts of a factor that promotes amylin aggregation or decreased amounts of a factor that clears amylin. 

Phrase: "Therefore,"

Phrase: "in type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "the balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014653:Balance [Organism Function]
  1000   C0205415:Balance [Functional Concept]
  1000   C0560184:Balance [Finding]

Phrase: "shifts from amylin clearance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0333051:Shift [Functional Concept]
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C1415831:AMYLIN [Gene or Genome]
   770   C2347509:Shift [Phenomenon or Process]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "to deposition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: "either by increased amounts of a factor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0960756:factor A [Organic Chemical]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1265611:amounts [Quantitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "amylin aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "or"

Phrase: "decreased amounts of a factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "that"

Phrase: "clears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.175: Although there have been numerous studies regarding amylin synthesis and secretion, at present there have been few studies of amylin degradation. 

Phrase: "Although"

Phrase: "there"

Phrase: "have"

Phrase: "been"

Phrase: "numerous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "regarding"

Phrase: "amylin synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "at present there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "few"

Phrase: "studies of amylin degradation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0243125:degradation [Functional Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0699900:Degradation [Organism Function]
   770   C0947630:studies [Laboratory Procedure]
   770   C1415831:AMYLIN [Gene or Genome]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.176: The enzyme responsible for the intracellular degradation of insulin is IDE, a cytosolic metallothioprotease also known as insulysin (11,26). 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "responsible for the intracellular degradation of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "is"

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a cytosolic metallothioprotease also"

Phrase: "known as insulysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0205309:Known [Qualitative Concept]
   790   C1415875:INSULYSIN [Gene or Genome]

Phrase: "(11,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.177: The primary function of IDE in mammalian tissues has traditionally been thought to be the degradation of insulin, but a number of other proteins have been identified as IDE substrates, including proteins structurally related to insulin, such as proinsulin, IGF-II, and relaxin, and seemingly unrelated peptides, such as ANP and glucagon (11). 

Phrase: "The primary function of IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "in mammalian tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "has"

Phrase: "traditionally"

Phrase: "been"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the degradation of insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "but"

Phrase: "a number of other proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified as IDE substrates,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   773   C0178623:enzyme substrate [Chemical Viewed Functionally]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205396:Identified [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   719   C1710236:Substrate [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "proteins structurally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "related to insulin,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C0163712:Relate [Organic Chemical]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "such as proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "IGF-II,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021666:IGF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:IGF2 [Gene or Genome]
  1000   C2697754:IGF2 [Laboratory Procedure]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "relaxin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035031:Relaxin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "seemingly unrelated peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "such as ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.178: However, insulin, ANP, and glucagon all contain regions that can form -pleated sheets and are potentially amyloid forming (27). 

Phrase: "However,"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "ANP,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "all"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "can"

Phrase: "form -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "pleated sheets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439643:Sheets [Spatial Concept]
   827 E C2349187:Sheet [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "potentially amyloid forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0205431:Forming [Functional Concept]
   827   C1522492:Forming [Functional Concept]
   793 E C0348078:Form [Qualitative Concept]
   793 E C0376315:Form [Manufactured Object]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.179: It has been proposed that rather than targeting a primary sequence motif, IDE is specific toward amyloidogenic peptides (28), a concept supported by findings that IDE also degrades amylin and -amyloid peptide (13,29,30). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that"

Phrase: "rather than"

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "a primary sequence motif,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "specific toward amyloidogenic peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "a concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concept [Idea or Concept]

Phrase: "supported by findings"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C1521721:Supported [Conceptual Entity]
   790   C2607943:findings [Functional Concept]
   790   C2926606:Findings [Clinical Attribute]
   790   C3539655:Findings [Intellectual Product]
   756 E C0037088:Finding [Sign or Symptom]
   756 E C0183683:Support [Medical Device]
   756 E C0243095:Finding [Finding]
   756 E C2825141:Finding [Finding]

Phrase: "that IDE also"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "degrades"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and -"

Phrase: "amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(13,"

Phrase: "29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.180: Recent studies have supported a role for IDE in type 2 diabetes and Alzheimers disease, two conditions characterized by amyloid. 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "a role for IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimers disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "two conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "characterized by amyloid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1880022:Characterized [Activity]
Processing 00000000.tx.181: Possible genetic linkages to type 2 diabetes and Alzheimers disease have been mapped to the chromosomal region of the IDE gene (3134). 

Phrase: "Possible genetic linkages to type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0314603:Genetic [Functional Concept]
   746   C0260581:birth type [Health Care Activity]
   745   C0023745:genetic linkage [Molecular Function]
           linkage

Phrase: "and"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "mapped to the chromosomal region of the IDE gene"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   775   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   775   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   756   C1333402:Enzyme Gene [Gene or Genome]
   756   C1953345:Chromosomal region [Cell]
           Region of chromosome
   754   C0008630:gene mapped [Laboratory Procedure,Molecular Biology Research Technique]
   754   C1337112:Insulin Gene [Gene or Genome]
   738   C0008633:Chromosomal [Cell Component]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0017337:Gene [Gene or Genome]
   738   C0017446:Region [Geographic Area]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0205147:Region [Spatial Concept]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]
   704   C0024779:Map [Manufactured Object]
   704   C1706473:Map [Conceptual Entity]
   701   C0814036:chromosome map [Intellectual Product]

Phrase: "(3134"

Phrase: ")."
Processing 00000000.tx.182: In the GK rat, a model of type 2 diabetes, IDE has been identified as a diabetes susceptibility gene; 

Phrase: "In the GK rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: "a model of type 2 diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "identified as a diabetes susceptibility gene"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0919453:Susceptibility Gene [Gene or Genome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0017337:Gene [Gene or Genome]
   753   C0205396:Identified [Qualitative Concept]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: ";"
Processing 00000000.tx.183: the mutations associated with this model result in lower cellular insulin degradation, hyperglycemia, reduced lipogenesis in fat cells, and reduced glucose uptake in vivo (35). 

Phrase: "the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with this model result"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   760   C3161035:Model [Intellectual Product]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in lower cellular insulin degradation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1523935:cellular degradation [Cell Function]
   861   C3547574:insulin degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]

Phrase: "hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "reduced lipogenesis in fat cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0596843:lipogenesis [Molecular Function]
   760   C1563744:Lipogenesis [Organism Function]

Phrase: "and"

Phrase: "reduced glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1159527:glucose uptake [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.184: The recently described IDE-null mouse model displays impaired insulin and -amyloid degradation, as well as hyperinsulinemia, glucose intolerance, and cerebral accumulation of -amyloid, hallmarks of both type 2 diabetes and Alzheimers disease (36). 

Phrase: "The recently described IDE-null mouse model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   836   C0596525:enzyme model [Research Activity]
   812   C2986594:Mouse Model [Experimental Model of Disease]
   793   C3161035:Model [Intellectual Product]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "impaired insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and -"

Phrase: "amyloid degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "as well as"

Phrase: "hyperinsulinemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "glucose intolerance,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0271650:Glucose Intolerance [Disease or Syndrome]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0231199:Intolerance [Organism Function]
   861   C1744706:intolerance [Intellectual Product]
   861   C2355652:Intolerance [Organism Attribute]
   789 E C0231200:Intolerant [Functional Concept]

Phrase: "and"

Phrase: "cerebral accumulation of -amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "hallmarks of both type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0011860:Type 2 Diabetes [Disease or Syndrome]
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.185: Thus, the evidence is mounting that IDE plays a major role in diseases characterized by amyloid formation. 

Phrase: "Thus,"

Phrase: "the evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "mounting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0181909:Mount [Medical Device]
   966   C0449878:mount [Finding]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a major role in diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "characterized by amyloid formation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1522492:Formation [Functional Concept]
   770   C1880022:Characterized [Activity]
Processing 00000000.tx.186: In a previous study using cell-free extracts (13), IDE readily degraded amylin, but with a lower affinity than for insulin. 

Phrase: "In a previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cell-free extracts"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   913   C0007592:Cell Extracts [Cell Component]
   901   C1183428:cell free [Cell]
   827   C0007634:Cell [Cell]
   827   C0332296:free [Functional Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1880497:Free [Qualitative Concept]
   827   C1948049:Cell [Spatial Concept]
   827   C1996904:Free [Qualitative Concept]
   793   C2828366:Extract [Substance]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "IDE readily degraded amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   799   C1415831:AMYLIN [Gene or Genome]

Phrase: "but with a lower affinity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0441994:Lower [Spatial Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "for insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.187: Radiolabeled amylin covalently cross-linked to IDE, and a monoclonal antibody directed against IDE immunoprecipitated both insulin- and amylin-degrading activities, confirming that IDE was the amylin-degrading protease. 

Phrase: "Radiolabeled amylin covalently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1415831:AMYLIN [Gene or Genome]

Phrase: "cross-linked to IDE,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   790   C0178576:Cross Linked [Natural Phenomenon or Process]
   790   C0332220:cross linked [Functional Concept]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2828360:Cross [Conceptual Entity]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "a monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "directed against IDE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "both insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin-degrading activities,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "the amylin-degrading protease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
Processing 00000000.tx.188: We have extended those findings to a rat -cellderived line. 

Phrase: "We"

Phrase: "have"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "those findings to a rat -cellderived line."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C2607943:findings [Functional Concept]
   748   C2926606:Findings [Clinical Attribute]
   748   C3539655:Findings [Intellectual Product]
   714 E C0037088:Finding [Sign or Symptom]
   714 E C0243095:Finding [Finding]
   714 E C2825141:Finding [Finding]
Processing 00000000.tx.189: Both amylin and insulin were degraded by RIN-m5F cells, but insulin was degraded much more slowly. 

Phrase: "Both amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "degraded by RIN-m5F cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C1419388:RIN [Gene or Genome]
   760   C1881707:DEGRADED [Phenomenon or Process]
   760   C1882531:RIN [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "much more slowly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439834:Slowly [Qualitative Concept]
Processing 00000000.tx.190: Possible reasons for this observation include differences in binding and internalization through the different receptors or differences in receptor availability (e.g., by desensitization or cell toxicity). 

Phrase: "Possible reasons for this observation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392360:reasons [Idea or Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "differences in binding"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "internalization through the different receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0599281:receptor internalization [Phenomenon or Process]
   760   C0871786:internalization [Mental Process]

Phrase: "or"

Phrase: "differences in receptor availability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "by desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "or"

Phrase: "cell toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.191: The differences may also be attributed to the nature of the assay. 

Phrase: "The differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "attributed to the nature of the assay."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]
   748   C1510438:Assay [Laboratory Procedure]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]
Processing 00000000.tx.192: Unlike amylin, multiple cleavages are required to produce TCA-soluble fragments of insulin, and therefore, this assay tends to underestimate the level of insulin degradation. 

Phrase: "Unlike amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "multiple cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "TCA-soluble fragments of insulin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "therefore,"

Phrase: "this assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "tends"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "underestimate"

Phrase: "the level of insulin degradation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0202098:Insulin level [Laboratory Procedure]
   797   C0428405:insulin level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.193: Amylin degradation began quickly, then leveled off with time. 

Phrase: "Amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "quickly,"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "leveled off"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0441889:Level [Qualitative Concept]
   799   C0456079:Level [Classification]
   799   C1547707:Level [Geographic Area]
   799   C2946261:Level [Pharmacologic Substance]

Phrase: "with time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.194: The probable explanation for this observation is based on insulin secretion by the cells. 

Phrase: "The probable explanation for this observation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "based on insulin secretion"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1527178:Based [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by the cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.195: The cells were changed into fresh media containing labeled substrates, so initially there was no endogenously produced insulin in the media. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "changed into fresh media"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0392747:Changed [Functional Concept]
   770   C0443172:Changed [Quantitative Concept]
   770   C0443224:Fresh [Qualitative Concept]
   770   C1254021:Media [Tissue]
   770   C2827486:Fresh [Body Substance]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C1705241:Change [Quantitative Concept]
   737 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "labeled substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "so"

Phrase: "initially there"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205265:Initially [Temporal Concept]

Phrase: "was"

Phrase: "no endogenously produced insulin in the media."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.196: RIN cells rapidly secreted insulin (reaching 510 nmol/l in 1 h), which would act as a competitive inhibitor of amylin degradation. 

Phrase: "RIN cells rapidly secreted insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "510 nmol/l in 1 h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C2827824:h*nmol/L [Quantitative Concept]
   790   C0439282:nmol/L [Quantitative Concept]
   783   C2346686:h l [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "would"

Phrase: "act as a competitive inhibitor of amylin degradation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   744   C0079613:ACT [Therapeutic or Preventive Procedure]
   744   C0243125:degradation [Functional Concept]
   744   C0679932:competitive [Social Behavior]
   744   C0699900:Degradation [Organism Function]
   744   C1415831:AMYLIN [Gene or Genome]
   744   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.197: Because the amylin was present in tracer amounts, sufficient insulin to competitively inhibit amylin degradation may well have been produced within 30 min. 

Phrase: "Because"

Phrase: "the amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "was"

Phrase: "present in tracer amounts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "sufficient insulin to competitively"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "may"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "have"

Phrase: "been"

Phrase: "produced within 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
Processing 00000000.tx.198: Both insulin and amylin were capable of competitive inhibition of either substrate, with insulin in general a better competitive inhibitor than amylin. 

Phrase: "Both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "were"

Phrase: "capable of competitive inhibition of either substrate,"

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in general"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "a better competitive inhibitor than amylin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.199: As discussed above, this is likely attributable to the greater affinity of insulin for IDE and possibly also to the different internalization properties for insulin and amylin. 

Phrase: "As"

Phrase: "discussed above,"

Phrase: "this"

Phrase: "is"

Phrase: "likely attributable to the greater affinity of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0596130:Attributable [Mental Process]

Phrase: "for IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "possibly also to the different internalization properties"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0871161:properties [Qualitative Concept]
   748   C0871786:internalization [Mental Process]
   748   C1292721:properties [Functional Concept]
   748   C1705242:Different [Qualitative Concept]
   748   C2362652:Possibly [Qualitative Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]

Phrase: "for insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.200: The efficiency of unlabeled insulin inhibition of insulin degradation was consistent with that in previous reports showing a 50% inhibition of 50100 nmol/l insulin using RIN-m5F cells (37). 

Phrase: "The efficiency of unlabeled insulin inhibition of insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0013682:Efficiency [Quantitative Concept]

Phrase: "was"

Phrase: "consistent with that"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "in previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 50% inhibition of 50100 nmol/l insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.201: Taken together, the data suggest that insulin and amylin share a common pathway of degradation. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a common pathway of degradation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1511758:Degradation Pathway [Conceptual Entity]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.202: The specificity of amylin- and insulin-degrading activity was investigated using the IDE inhibitor bacitracin. 

Phrase: "The specificity of amylin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "and"

Phrase: "insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the IDE inhibitor bacitracin."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   708   C0021643:insulin inhibitor [Pharmacologic Substance]
Processing 00000000.tx.203: Although bacitracin is not a specific inhibitor of IDE, other IDE inhibitors (e.g., N-ethylmaleimide and 1,10-phenanthroline) were highly toxic to RIN-m5F cells (R.G.B., unpublished observations), whereas bacitracin was well tolerated by the cells. 

Phrase: "Although"

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a specific inhibitor of IDE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   774   C0021643:insulin inhibitor [Pharmacologic Substance]
   774   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "other IDE inhibitors"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   886   C0021643:insulin inhibitor [Pharmacologic Substance]
   861   C0014432:Enzyme Inhibitors [Pharmacologic Substance]
   861   C1152555:enzyme inhibitors [Molecular Function]
   861   C2756995:Enzyme Inhibitors [Molecular Function]
   827 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "N-ethylmaleimide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015101:N-Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ethylmaleimide

Phrase: "and"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10-phenanthroline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: ")"

Phrase: "were"

Phrase: "highly toxic to RIN-m5F cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0600688:toxic [Injury or Poisoning]
   753   C1407029:Toxic [Qualitative Concept]

Phrase: "(R.G.B.,"

Phrase: "unpublished observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "was"

Phrase: "well tolerated by the cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2347578:Cells/well [Quantitative Concept]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]
Processing 00000000.tx.204: Amylin and insulin degradation by RIN-m5F cells was markedly inhibited by bacitracin. 

Phrase: "Amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin degradation by RIN-m5F cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "inhibited by bacitracin."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   790   C0311403:Inhibited [Qualitative Concept]
   734 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
Processing 00000000.tx.205: Bacitracin also accelerated islet amyloid formation at all amylin concentrations, suggesting that inhibition of amylin degradation accelerates amylin aggregation and amyloid deposition. 

Phrase: "Bacitracin also accelerated islet amyloid formation at all amylin concentrations,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C3547593:bacitracin formation [Molecular Function]
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C1522492:Formation [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that inhibition of amylin degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "amylin aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "amyloid deposition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.206: Because amylin has been implicated in -cell death, cell viability was examined under the same conditions. 

Phrase: "Because"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "implicated"

Phrase: "in -cell death,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007587:Cell Death [Cell Function]
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]

Phrase: "cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "examined under the same conditions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332128:Examined [Finding]
   760   C0445247:Same [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.207: Cytotoxicity induced by human amylin was markedly increased with bacitracin treatment, whereas rat amylin had no effect, suggesting that amylin degradation is responsible for reducing cell toxicity caused by amylin. 

Phrase: "Cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "induced by human amylin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0086418:Human [Human]
   770   C0205263:Induced [Functional Concept]
   770   C1415831:AMYLIN [Gene or Genome]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "increased with bacitracin treatment,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "whereas"

Phrase: "rat amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "had"

Phrase: "no effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "responsible for reducing cell toxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "caused by amylin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   790   C1415831:AMYLIN [Gene or Genome]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.208: Amylin-induced cytotoxicity in -cells has been shown to be caused by intermediate amylin precursors rather than mature amyloid (3). 

Phrase: "Amylin-induced cytotoxicity in -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   800   C0022686:Cytotoxic cell [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "caused by intermediate amylin precursors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   760   C0205103:Intermediate [Spatial Concept]
   760   C1415831:AMYLIN [Gene or Genome]
   760   C1550465:intermediate [Idea or Concept]
   760   C2827755:INTERMEDIATE [Laboratory or Test Result]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
   726   C1709634:Precursor [Idea or Concept]

Phrase: "rather than"

Phrase: "mature amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.209: If IDE degrades amylin monomers, then the formation of both intermediate precursors and amyloid fibrils would be prevented. 

Phrase: "If"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "degrades"

Phrase: "amylin monomers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the formation of both intermediate precursors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "amyloid fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "would"

Phrase: "be"

Phrase: "prevented."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.210: The experiments performed here (48-h treatment of freshly prepared amylin) cannot determine which amylin species caused toxicity in RIN cells. 

Phrase: "The experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "here"

Phrase: "(48-h treatment of freshly prepared amylin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: ")"

Phrase: "cannot"

Phrase: "determine"

Phrase: "which amylin species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "toxicity in RIN cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.211: However, the degree of cell death seen with bacitracin treatment was increased to the maximum attained, even at the lowest amylin concentration, which could mean that the toxicity preceded amyloid deposition. 

Phrase: "However,"

Phrase: "the degree of cell death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "seen with bacitracin treatment"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205397:Seen [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
   715 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "was"

Phrase: "increased to the maximum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0806909:Maximum [Quantitative Concept]
   770   C1552615:maximum [Quantitative Concept]
   770   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "attained"

Phrase: ","

Phrase: "even at the lowest amylin concentration,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   753   C0086045:Concentration [Mental Process]
   753   C1415831:AMYLIN [Gene or Genome]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1708760:Lowest [Qualitative Concept]
   719 E C0205251:low [Qualitative Concept]
   719 E C1299352:Low [Qualitative Concept]
   719 E C1550472:low [Idea or Concept]

Phrase: "which"

Phrase: "could"

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "that"

Phrase: "the toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "preceded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:preceded [Temporal Concept]

Phrase: "amyloid deposition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.212: Although the amylin concentration required for detection of amyloid and cell toxicity (10100 nmol/l) is high relative to circulating levels, the local amylin concentration around -cells is unknown, but may well be higher, especially under conditions that stimulate insulin and amylin secretion. 

Phrase: "Although"

Phrase: "the amylin concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "required for detection of amyloid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
   760   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "cell toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "(10100 nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439191:NMOLE [Quantitative Concept]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "is"

Phrase: "high relative to circulating levels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "the local amylin concentration around -cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "is"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: "may"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "be"

Phrase: "higher, especially under conditions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   737   C0012634:condition [Disease or Syndrome]
   737   C0205250:High [Qualitative Concept]
   737   C0348080:Condition [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "that"

Phrase: "stimulate"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.213: In summary, RIN-m5F cells clear amylin through a bacitracin-sensitive mechanism with properties consistent with those of IDE. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "RIN-m5F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "amylin through a bacitracin-sensitive mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   753   C1415831:AMYLIN [Gene or Genome]

Phrase: "with properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]

Phrase: "consistent with those of IDE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.214: Inhibition of this mechanism increased amyloid formation and cell toxicity. 

Phrase: "Inhibition of this mechanism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "cell toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.215: These data are consistent with the emerging concept of a role for IDE in diseases characterized by amyloid. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the emerging concept of a role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "characterized by amyloid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1880022:Characterized [Activity]
Processing 00000000.tx.216: In this regard, it is interesting to note again that transgenic animals expressing human amylin in general do not develop islet amyloid unless diabetic conditions are introduced. 

Phrase: "In this regard,"

Phrase: "it"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "again"

Phrase: "that transgenic animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003069:Animals, Transgenic [Animal]
   861   C0003062:Animals [Animal]

Phrase: "expressing"

Phrase: "human amylin in general"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C1415831:AMYLIN [Gene or Genome]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "unless"

Phrase: "diabetic conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "are"

Phrase: "introduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]
Processing 00000000.tx.217: One of these conditions is a high-fat diet (9). 

Phrase: "One of these conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "a high-fat diet"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.218: Interestingly, it has been shown that increased lipid levels result in impaired insulin degradation (38) and free fatty acids directly inhibit IDE activity (39). 

Phrase: "Interestingly,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that increased lipid levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0851043:Increased lipid [Finding]
   867   C0428460:Lipid level [Laboratory or Test Result]
   827   C0023779:Lipid [Lipid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "result in impaired insulin degradation"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C3547574:insulin degradation [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0221099:Impaired [Functional Concept]
   760   C0243125:degradation [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C0699900:Degradation [Organism Function]
   760   C1274040:Result [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1546471:Result [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2825142:Result [Finding]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(38"

Phrase: ")"

Phrase: "and"

Phrase: "free fatty acids directly"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0015688:Free Fatty Acids [Lipid]
   890 E C2698488:Free Fatty Acid [Laboratory Procedure]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0332296:free [Functional Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "IDE activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   902   C1145751:insulin activity [Molecular Function]
   861   C0243102:enzyme activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.219: The combination of increased expression of amyloidogenic amylin and impaired insulin-degrading activity may result in the formation of islet amyloid in these models. 

Phrase: "The combination of increased expression of amyloidogenic amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205195:Combination [Qualitative Concept]
   744   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "impaired insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   875   C1145751:insulin activity [Molecular Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1561536:*Activity [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "result in the formation of islet amyloid"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1274040:Result [Functional Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "in these models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]
Processing 00000000.tx.220: Therefore, it is possible that conditions leading to impaired IDE activity (e.g., elevated free fatty acids) contribute to amylin accumulation and aggregation, -cell toxicity, islet amyloid formation, and the progression of type 2 diabetes.  

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "leading to impaired IDE activity"
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   778   C0243102:enzyme activity [Molecular Function]
   774   C1145751:insulin activity [Molecular Function]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0221099:Impaired [Functional Concept]
   748   C0332152:Leading [Temporal Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0684336:Impaired [Pathologic Function]
   748   C1522538:Leading [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1561536:*Activity [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "contribute to amylin accumulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C1415831:AMYLIN [Gene or Genome]
   770   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "aggregation, -"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "cell toxicity,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "islet amyloid formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "the progression of type 2 diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0242656:progression [Pathologic Function]
   753   C0449258:Progression [Functional Concept]
Processing 00000000.tx.221: ACKNOWLEDGMENTS  This work was supported by the U.S. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the U.S."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0041703:U S [Geographic Area]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]
Processing 00000000.tx.222: Department of Veterans Affairs Research Service and the Bly Memorial Research Fund, University of Nebraska Medical Center. 

Phrase: "Department of Veterans Affairs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C3496098:Department of Veterans Affairs [Health Care Related Organization]
   861   C1549054:Veterans Affairs [Organization]
   812   C0042610:Veterans [Population Group]
   812   C1704729:Department [Organization]
   779 E C3245459:veteran [Intellectual Product]

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Service"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557854:Service [Occupational Activity]
  1000   C2825316:Service [Manufactured Object]
  1000   C3245478:service [Idea or Concept]

Phrase: "and"

Phrase: "the Bly Memorial Research Fund,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681805:research fund [Research Activity]
   812   C0016820:Fund [Quantitative Concept]

Phrase: "University of Nebraska Medical Center."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
Processing 00000000.tx.223: Address correspondence and reprint requests to Robert G. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Robert G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439267:g% [Quantitative Concept]
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]
Processing 00000000.tx.224: Bennett, PhD, Research Service (151), Veterans Affairs Medical Center, 4101 Woolworth Ave., Omaha, NE 68105. 

Phrase: "Bennett,"

Phrase: "PhD,"

Phrase: "Research Service"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557854:Service [Occupational Activity]
   861   C2825316:Service [Manufactured Object]
   861   C3245478:service [Idea or Concept]

Phrase: "(151"

Phrase: ")"

Phrase: ","

Phrase: "Veterans Affairs Medical Center,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1549054:Veterans Affairs [Organization]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0042610:Veterans [Population Group]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]
   779 E C3245459:veteran [Intellectual Product]

Phrase: "4101 Woolworth Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "NE 68105."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:NE [Gene or Genome]
Processing 00000000.tx.225: E-mail: rgbennet{at}unmc.edu Received for publication January 15, 2003 and accepted in revised form June 3, 2003 ANP, atrial natriuretic peptide; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "rgbennet{at}unmc.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication January 15,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2003"

Phrase: "and"

Phrase: "accepted in revised form June 3,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2003 ANP,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   861   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   812   C0018792:Atrial [Body Part, Organ, or Organ Component]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0597421:natriuretic [Pharmacologic Substance]
   741 E C0524422:atria [Body Part, Organ, or Organ Component]
   741 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "atrial natriuretic peptide"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.226: IDE, insulin-degrading enzyme; 

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.227: MTT, methylthiazolyldiphenyl-tetrazolium bromide; 

Phrase: "MTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006222:Bromide [Inorganic Chemical]

Phrase: "methylthiazolyldiphenyl-tetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006222:Bromide [Inorganic Chemical]

Phrase: ";"
Processing 00000000.tx.228: TCA, trichloroacetic acid  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Kahn SE, Andrikopoulos S, Verchere CB: Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.Diabetes48:241253,1999[Abstract/Free FullText] Kahn SE, DAlessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ Jr, Porte D Jr: Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.Diabetes39:634638,1990[Abstract] Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.Diabetes48:491498,1999[Abstract] Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC: Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.Proc Natl Acad Sci U S A93:72837288,1996[Abstract/Free FullText] Verchere CB, DAlessio DA, Wang S, Andrikopoulos S, Kahn SE: Transgenic overproduction of islet amyloid polypeptide (amylin) is not sufficient for islet amyloid formation.Horm Metab Res29:311316,1997[Medline] Hoppener JW, Verbeek JS, de Koning EJ, Oosterwijk C, van Hulst KL, Visser-Vernooy HJ, Hofhuis FM, van Gaalen S, Berends MJ, Hackeng WH, et al: Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia.Diabetologia36:12581265,1993[Medline] Fox N, Schrementi J, Nishi M, Ohagi S, Chan SJ, Heisserman JA, Westermark GT, Leckstrom A, Westermark P, Steiner DF: Human islet amyloid polypeptide transgenic mice as a model of non- insulin-dependent diabetes mellitus (NIDDM).FEBS Lett323:4044,1993[Medline] Couce M, Kane LA, OBrien TD, Charlesworth J, Soeller W, McNeish J, Kreutter D, Roche P, Butler PC: Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction.Diabetes45:10941101,1996[Abstract] Verchere CB, DAlessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.Proc Natl Acad Sci U S A93:34923496,1996[Abstract/Free FullText] Hoppener JW, Oosterwijk C, Nieuwenhuis MG, Posthuma G, Thijssen JH, Vroom TM, Ahren B, Lips CJ: Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.Diabetologia42:427434,1999[Medline] Duckworth WC, Bennett RG, Hamel FG: Insulin degradation: progress and potential.Endocr Rev19:608624,1998[Abstract/Free FullText] Kurochkin IV: Insulin-degrading enzyme: embarking on amyloid destruction.

Phrase: "TCA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "trichloroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Kahn SE,"

Phrase: "Andrikopoulos S,"

Phrase: "Verchere CB"

Phrase: ":"

Phrase: "Islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a long-recognized"

Phrase: "but"

Phrase: "underappreciated pathological feature of type 2 diabetes.Diabetes48"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1521970:Feature [Qualitative Concept]
   744   C1706388:Feature [Conceptual Entity]
   744   C2346469:Feature [Qualitative Concept]
   744   C2348519:Feature [Qualitative Concept]

Phrase: ":"

Phrase: "241253,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kahn SE,"

Phrase: "DAlessio DA,"

Phrase: "Schwartz MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Fujimoto WY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043287:WY [Geographic Area]

Phrase: "Ensinck JW,"

Phrase: "Taborsky GJ Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Porte D Jr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: ":"

Phrase: "Evidence of cosecretion of islet amyloid polypeptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "insulin by beta-cells.Diabetes39"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   781   C0030281:Insulin Cell [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ":"

Phrase: "634638,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Janson J,"

Phrase: "Ashley RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Harrison D,"

Phrase: "McIntyre S,"

Phrase: "Butler PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: ":"

Phrase: "The mechanism of islet amyloid polypeptide toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "membrane disruption by intermediate-sized toxic amyloid particles.Diabetes48"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332453:Disruption [Functional Concept]

Phrase: ":"

Phrase: "491498,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Janson J,"

Phrase: "Soeller WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Roche PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Nelson RT,"

Phrase: "Torchia AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Kreutter DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "Butler PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: ":"

Phrase: "Spontaneous diabetes mellitus in transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   753   C0011847:Diabetes [Disease or Syndrome]

Phrase: "expressing"

Phrase: "human islet amyloid polypeptide.Proc Natl Acad Sci U S A93"

Phrase: ":"

Phrase: "72837288,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Verchere CB,"

Phrase: "DAlessio DA,"

Phrase: "Wang S,"

Phrase: "Andrikopoulos S,"

Phrase: "Kahn SE"

Phrase: ":"

Phrase: "Transgenic overproduction of islet amyloid polypeptide"

Phrase: "(amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "not sufficient for islet amyloid formation.Horm Metab Res29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205410:Sufficient [Qualitative Concept]

Phrase: ":"

Phrase: "311316,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hoppener JW,"

Phrase: "Verbeek JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "de Koning EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1718783:Ej [Immunologic Factor]

Phrase: "Oosterwijk C,"

Phrase: "van Hulst KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1366480:KL [Gene or Genome]
   827   C1416656:KL [Gene or Genome]

Phrase: "Visser-Vernooy HJ,"

Phrase: "Hofhuis FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "van Gaalen S,"

Phrase: "Berends MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Hackeng WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: "et al"

Phrase: ":"

Phrase: "Chronic overproduction of islet amyloid polypeptide/amylin"

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ":"

Phrase: "lysosomal localization of human islet amyloid polypeptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
   743   C1819332:lysosome localisation [Biologic Function]

Phrase: "and"

Phrase: "lack of marked hyperglycaemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "or"

Phrase: "hyperinsulinaemia.Diabetologia36"

Phrase: ":"

Phrase: "12581265,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fox N,"

Phrase: "Schrementi J,"

Phrase: "Nishi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ohagi S,"

Phrase: "Chan SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Heisserman JA,"

Phrase: "Westermark GT,"

Phrase: "Leckstrom A,"

Phrase: "Westermark P,"

Phrase: "Steiner DF"

Phrase: ":"

Phrase: "Human islet amyloid polypeptide transgenic mice as a model"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0025936:Mice, Transgenic [Mammal]
   762   C1519606:Transgenic Model [Experimental Model of Disease]
   745   C2986594:Mouse Model [Experimental Model of Disease]
   742   C0003069:Transgenic [Animal]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "of non- insulin-dependent diabetes mellitus (NIDDM).FEBS Lett323"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   747   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   747   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   710   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]

Phrase: ":"

Phrase: "4044,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Couce M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kane LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "OBrien TD,"

Phrase: "Charlesworth J,"

Phrase: "Soeller W,"

Phrase: "McNeish J,"

Phrase: "Kreutter D,"

Phrase: "Roche P,"

Phrase: "Butler PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: ":"

Phrase: "Treatment with growth hormone"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   881   C0744483:growth hormone treatment [Disease or Syndrome]
   819   C0279025:hormone treatment [Therapeutic or Preventive Procedure]
   819   C2966671:Hormone treatment [Clinical Attribute]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "dexamethasone in mice"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   734 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   734 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   734 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "transgenic for human islet amyloid polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003069:Transgenic [Animal]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "islet amyloidosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "and"

Phrase: "beta-cell dysfunction.Diabetes45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1969875:Beta-cell dysfunction [Finding]

Phrase: ":"

Phrase: "10941101,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Verchere CB,"

Phrase: "DAlessio DA,"

Phrase: "Palmiter RD,"

Phrase: "Weir GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Bonner-Weir S,"

Phrase: "Baskin DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Kahn SE"

Phrase: ":"

Phrase: "Islet amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "associated with hyperglycemia"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0020456:Hyperglycaemia [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "with pancreatic beta cell expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0030281:Pancreatic beta cell [Cell]

Phrase: "of human islet amyloid polypeptide.Proc Natl Acad Sci U S A93"

Phrase: ":"

Phrase: "34923496,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoppener JW,"

Phrase: "Oosterwijk C,"

Phrase: "Nieuwenhuis MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Posthuma G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Thijssen JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Vroom TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Ahren B,"

Phrase: "Lips CJ"

Phrase: ":"

Phrase: "Extensive islet amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "induced by development of type II diabetes mellitus"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   833   C2984301:Type II diabetes mellitus [Functional Concept]
   770   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   770   C0441730:Type II [Classification]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0205263:Induced [Functional Concept]
   744   C0243107:development [Physiologic Function]
   744   C0332307:Type [Qualitative Concept]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "contributes to its progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1880177:Contribute [Activity]

Phrase: ":"

Phrase: "pathogenesis of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0543483:pathogenesis [Functional Concept]
   790   C0699748:Pathogenesis [Pathologic Function]

Phrase: "in a mouse model.Diabetologia42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2986594:Mouse Model [Experimental Model of Disease]

Phrase: ":"

Phrase: "427434,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "and"

Phrase: "potential.Endocr Rev19"

Phrase: ":"

Phrase: "608624,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kurochkin IV"

Phrase: ":"

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "embarking on amyloid destruction."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1261381:Destruction [Therapeutic or Preventive Procedure]
   770   C1948029:Destruction [Activity]
Processing 00000000.tx.229: Trends Biochem Sci26:421425,2001[Medline] Bennett RG, Duckworth WC, Hamel FG: Degradation of amylin by insulin-degrading enzyme.J Biol Chem275:3662136625,2000[Abstract/Free FullText] Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, Rosner MR, Selkoe DJ: Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.J Neurosci20:16571665,2000[Abstract/Free FullText] Shii K, Roth RA: Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.Proc Natl Acad Sci U S A83:41474151,1986[Abstract] Bhathena SJ, Oie HK, Gazdar AF, Voyles NR, Wilkins SD, Recant L: Insulin, glucagon, and somatostatin receptors on cultured cells and clones from rat islet cell tumor.Diabetes31:521531,1982[Abstract] Peavy DE, Edmondson JW, Duckworth WC: Selective effects of inhibitors of hormone processing on insulin action in isolated hepatocytes.Endocrinology114:753760,1984[Abstract] Churukian CJ: Improved Puchtlers Congo red method for demonstrating amyloid.J Histotechnol23:139141,2000 Hansen MB, Nielsen SE, Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.J Immunol Methods119:203210,1989[Medline] Westermark P, Li ZC, Westermark GT, Leckstrom A, Steiner DF: Effects of beta cell granule components on human islet amyloid polypeptide fibril formation.FEBS Lett379:203206,1996[Medline] Puchtler H, Sweat F, Levine M: On the binding of Congo red by amyloid.J Histochem Cytochem10:355364,1962 Howard CF: Longitudinal studies on the development of diabetes in individual Macaca nigra.Diabetologia29:301306,1986[Medline] Kahn SE, Verchere CB, Andrikopoulos S, Asberry PJ, Leonetti DL, Wahl PW, Boyko EJ, Schwartz RS, Newell-Morris L, Fujimoto WY: Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.Diabetes47:640645,1998[Abstract] Westermark P: Amyloid and polypeptide hormones. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem Sci26"

Phrase: ":"

Phrase: "421425,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Hamel FG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: ":"

Phrase: "Degradation of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "by insulin-degrading enzyme.J Biol Chem275"

Phrase: ":"

Phrase: "3662136625,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vekrellis K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ye Z,"

Phrase: "Qiu WQ,"

Phrase: "Walsh D,"

Phrase: "Hartley D,"

Phrase: "Chesneau V,"

Phrase: "Rosner MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Selkoe DJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: ":"

Phrase: "Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "regulate"

Phrase: "extracellular levels of amyloid beta-protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "via proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "by insulin-degrading enzyme.J Neurosci20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: ":"

Phrase: "16571665,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shii K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Roth RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: ":"

Phrase: "Inhibition of insulin degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0677626:hepatoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0023903:Hepatoma [Neoplastic Process]
   861   C2239176:Hepatoma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "after microinjection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025991:Microinjection [Therapeutic or Preventive Procedure]

Phrase: "of monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to a specific cytosolic protease.Proc Natl Acad Sci U S A83"

Phrase: ":"

Phrase: "41474151,"

Phrase: "1986"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bhathena SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Oie HK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "Gazdar AF,"

Phrase: "Voyles NR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027496:NR [Geographic Area]

Phrase: "Wilkins SD,"

Phrase: "Recant"

Phrase: "L"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "somatostatin receptors on cultured cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0074830:Receptors, Somatostatin [Amino Acid, Peptide, or Protein,Receptor]
   797   C0524984:Somatostatin Cells [Cell]
   764   C1514760:Receptor Cell [Cell]
   760   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "clones from rat islet cell tumor.Diabetes31"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   814   C0242363:Islet Cell Tumor [Neoplastic Process]
   814   C1337011:Islet Cell Tumor [Neoplastic Process]
   778   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   778   C1522529:Islet Cell [Cell]
   774   C0009013:Cell Clone [Cell]
           Clone
   774   C0431085:Tumor cell [Cell]
   774   C0597032:Tumor Cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0027651:Tumor [Neoplastic Process]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C1269647:Cell [Cell]
   748   C1522642:Clone [Tissue]
   748   C1578706:Tumor [Intellectual Product]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3273930:Tumor [Finding]

Phrase: ":"

Phrase: "521531,"

Phrase: "1982"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Peavy DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Edmondson JW,"

Phrase: "Duckworth WC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: ":"

Phrase: "Selective effects of inhibitors of hormone processing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in isolated hepatocytes.Endocrinology114"

Phrase: ":"

Phrase: "753760,"

Phrase: "1984"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Churukian CJ"

Phrase: ":"

Phrase: "Improved Puchtlers Congo red method for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "demonstrating"

Phrase: "amyloid.J Histotechnol23"

Phrase: ":"

Phrase: "139141,"

Phrase: "2000 Hansen MB,"

Phrase: "Nielsen SE,"

Phrase: "Berg K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Re-examination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "and"

Phrase: "further development of a precise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "rapid dye method for measuring cell growth/cell kill.J Immunol Methods119"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C0872257:rapid method [Diagnostic Procedure]
   736   C0025663:Method [Intellectual Product]
   736   C0449851:Method [Functional Concept]
   736   C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "203210,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Westermark P,"

Phrase: "Li ZC,"

Phrase: "Westermark GT,"

Phrase: "Leckstrom A,"

Phrase: "Steiner DF"

Phrase: ":"

Phrase: "Effects of beta cell granule components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on human islet amyloid polypeptide fibril formation.FEBS Lett379"

Phrase: ":"

Phrase: "203206,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Puchtler H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Sweat F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Levine M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "On the binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "of Congo red"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009742:Congo Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0009738:Congo [Geographic Area]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "by amyloid.J Histochem Cytochem10"

Phrase: ":"

Phrase: "355364,"

Phrase: "1962 Howard CF"

Phrase: ":"

Phrase: "Longitudinal studies on the development of diabetes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C0023981:Longitudinal Studies [Research Activity]
   748   C0205127:Longitudinal [Spatial Concept]
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "in individual Macaca nigra.Diabetologia29"

Phrase: ":"

Phrase: "301306,"

Phrase: "1986"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kahn SE,"

Phrase: "Verchere CB,"

Phrase: "Andrikopoulos S,"

Phrase: "Asberry PJ,"

Phrase: "Leonetti DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Wahl PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Boyko EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Schwartz RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Newell-Morris L,"

Phrase: "Fujimoto WY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043287:WY [Geographic Area]

Phrase: ":"

Phrase: "Reduced amylin release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a characteristic of impaired glucose tolerance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521970:Characteristic [Qualitative Concept]

Phrase: "and"

Phrase: "type 2 diabetes in Japanese Americans.Diabetes47"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0011860:Type 2 Diabetes [Disease or Syndrome]
   778   C0441730:Type 2 [Classification]
   774   C1320657:Diabetes type [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "640645,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Westermark P"

Phrase: ":"

Phrase: "Amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "polypeptide hormones."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0312439:Polypeptide Hormones [Amino Acid, Peptide, or Protein,Hormone]
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]
Processing 00000000.tx.230: What is their relationship?Amyloid1:4760,1994 DAlessio DA, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD, Ensinck JW: Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse.Diabetes43:14571461,1994[Abstract] Becker AB, Roth RA: Insulysin and pitrilysin: insulin-degrading enzymes of mammals and bacteria.Meth Enzymol248:693703,1995[Medline] Sipe JD: Amyloidosis.Annu Rev Biochem61:947975,1992[Medline] Kurochkin IV: Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme.FEBS Lett427:153156,1998[Medline] Goto S, Kurochkin IV: Alzheimerss -amyloid peptide interacts with and is degraded by insulin degrading enzyme.FEBS Lett345:3337,1994[Medline] Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR, Safavi A, Hersh LB, Selkoe DJ: Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.J Biol Chem273:3273032738,1998[Abstract/Free FullText] Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M, ORahilly S, Frayling TM, Bell JI, Lathrop GM, Bennett A, Dhillon R, Fletcher C, Groves CJ, Jones E, Prestwich P, Simecek N, Rao PV, Wishart M, Bottazzo GF, Foxon R, Howell S, Smedley D, Cardon LR, Menzel S, McCarthy MI: A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q.

Phrase: "What"

Phrase: "is"

Phrase: "their relationship?Amyloid1"

Phrase: ":"

Phrase: "4760,"

Phrase: "1994 DAlessio DA,"

Phrase: "Verchere CB,"

Phrase: "Kahn SE,"

Phrase: "Hoagland V,"

Phrase: "Baskin DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Palmiter RD,"

Phrase: "Ensinck JW"

Phrase: ":"

Phrase: "Pancreatic expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "secretion of human islet amyloid polypeptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "in a transgenic mouse.Diabetes43"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0025936:Mouse, Transgenic [Mammal]

Phrase: ":"

Phrase: "14571461,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Becker AB,"

Phrase: "Roth RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: ":"

Phrase: "Insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "and"

Phrase: "pitrilysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0208233:pitrilysin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "insulin-degrading enzymes of mammals"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   828   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   828   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "bacteria.Meth Enzymol248"

Phrase: ":"

Phrase: "693703,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sipe JD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: ":"

Phrase: "Amyloidosis.Annu Rev Biochem61"

Phrase: ":"

Phrase: "947975,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kurochkin IV"

Phrase: ":"

Phrase: "Amyloidogenic determinant as a substrate recognition motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521761:Determinant [Functional Concept]

Phrase: "of insulin-degrading enzyme.FEBS Lett427"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: ":"

Phrase: "153156,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Goto S,"

Phrase: "Kurochkin IV"

Phrase: ":"

Phrase: "Alzheimerss -amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacts with"

Phrase: "and"

Phrase: "is"

Phrase: "degraded by insulin degrading enzyme.FEBS Lett345"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1881707:DEGRADED [Phenomenon or Process]

Phrase: ":"

Phrase: "3337,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Qiu WQ,"

Phrase: "Walsh DM,"

Phrase: "Ye Z,"

Phrase: "Vekrellis K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Zhang J,"

Phrase: "Podlisny MB,"

Phrase: "Rosner MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Safavi A,"

Phrase: "Hersh LB,"

Phrase: "Selkoe DJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: ":"

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "extracellular levels of amyloid beta-protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "by degradation.J Biol Chem273"

Phrase: ":"

Phrase: "3273032738,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wiltshire S,"

Phrase: "Hattersley AT,"

Phrase: "Hitman GA,"

Phrase: "Walker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Levy JC,"

Phrase: "Sampson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "ORahilly S,"

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Bell JI,"

Phrase: "Lathrop GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Bennett A,"

Phrase: "Dhillon R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Fletcher C,"

Phrase: "Groves CJ,"

Phrase: "Jones E,"

Phrase: "Prestwich P,"

Phrase: "Simecek N,"

Phrase: "Rao PV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032463:PV [Neoplastic Process]

Phrase: "Wishart M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bottazzo GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Foxon R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Howell S,"

Phrase: "Smedley D,"

Phrase: "Cardon LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "Menzel S,"

Phrase: "McCarthy MI"

Phrase: ":"

Phrase: "A genomewide scan for loci"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034606:Scan [Diagnostic Procedure]
   760   C0441633:Scan [Diagnostic Procedure]
   760   C2826292:SCAN [Finding]

Phrase: "predisposing to type 2 diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0231203:predisposing [Functional Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "in a U.K. population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]

Phrase: "("

Phrase: "the Diabetes UK Warren 2 Repository"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0872261:Repository [Manufactured Object]

Phrase: ")"

Phrase: ":"

Phrase: "analysis of 573 pedigrees"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "independent replication of a susceptibility locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0598312:Replication [Genetic Function]
   753   C1883725:replication [Qualitative Concept]

Phrase: "on chromosome 1q."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327882:chromosome 1q [Nucleotide Sequence]
           1q
Processing 00000000.tx.231: Am J Hum Genet69:553569,2001[Medline] Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, Yhu S, McInnis MG, Go RC, Vekrellis K, Selkoe DJ, Saunders AJ, Tanzi RE: Evidence for genetic linkage of Alzheimerss disease to chromosome 10q.Science290:23022303,2000[Abstract/Free FullText] Myers A, Holmans P, Marshall H, Kwon J, Meyer D, Ramic D, Shears S, Booth J, DeVrieze FW, Crook R, Hamshere M, Abraham R, Tunstall N, Rice F, Carty S, Lillystone S, Kehoe P, Rudrasingham V, Jones L, Lovestone S, Perez-Tur J, Williams J, Owen MJ, Hardy J, Goate AM: Susceptibility locus for Alzheimerss disease on chromosome 10.Science290:23042305,2000[Abstract/Free FullText] Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin SG: Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimerss disease pedigrees.Science290:23032304,2000[Abstract/Free FullText] Fakhrai-Rad H, Nikoshkov A, Kamel A, Fernstrom M, Zierath JR, Norgren S, Luthman H, Galli J: Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats.Hum Mol Genet9:21492158,2000[Abstract/Free FullText] Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S: Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.Proc Natl Acad Sci U S A100:41624167,2003[Abstract/Free FullText] Bhathena SJ, Timmers KI, Oie HK, Voyles NR, Recant L: Cytosolic insulin-degrading activity in islet-derived tumor cell lines and in normal rat islets.Diabetes34:121128,1985[Abstract] Oehler G, Bleyl H, Matthes KJ: Hyperinsulinemia in hepatic steatosis.Int J Obe Relat Metab Disord6 (Suppl. 1):137144,1982 Hamel FG, Upward JL, Bennett RG: In vitro inhibition of insulin-degrading enzyme by long chain fatty acids and their coenzyme A thioesters.Endocrinology144:24042408,2003[Abstract/Free FullText]

Phrase: "Am"

Phrase: "J Hum Genet69"

Phrase: ":"

Phrase: "553569,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bertram L,"

Phrase: "Blacker D,"

Phrase: "Mullin K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Keeney D,"

Phrase: "Jones J,"

Phrase: "Basu S,"

Phrase: "Yhu S,"

Phrase: "McInnis MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419366:RC [Gene or Genome]

Phrase: "Vekrellis K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Selkoe DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Saunders AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Tanzi RE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: ":"

Phrase: "Evidence for genetic linkage of Alzheimerss disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "to chromosome 10q.Science290"

Phrase: ":"

Phrase: "23022303,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Myers A,"

Phrase: "Holmans P,"

Phrase: "Marshall H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kwon J,"

Phrase: "Meyer D,"

Phrase: "Ramic D,"

Phrase: "Shears S,"

Phrase: "Booth J,"

Phrase: "DeVrieze FW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332292:FW [Functional Concept]
   861   C2986896:FW [Idea or Concept]

Phrase: "Crook R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hamshere M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Abraham R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Tunstall N,"

Phrase: "Rice F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Carty S,"

Phrase: "Lillystone S,"

Phrase: "Kehoe P,"

Phrase: "Rudrasingham V,"

Phrase: "Jones L,"

Phrase: "Lovestone S,"

Phrase: "Perez-Tur J,"

Phrase: "Williams J,"

Phrase: "Owen MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Hardy J,"

Phrase: "Goate"

Phrase: "AM"

Phrase: ":"

Phrase: "Susceptibility locus for Alzheimerss disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708726:Locus [Gene or Genome]

Phrase: "on chromosome 10.Science290"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0008652:Chromosome 10 [Cell Component]

Phrase: ":"

Phrase: "23042305,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ertekin-Taner N,"

Phrase: "Graff-Radford N,"

Phrase: "Younkin LH,"

Phrase: "Eckman C,"

Phrase: "Baker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Adamson J,"

Phrase: "Ronald J,"

Phrase: "Blangero J,"

Phrase: "Hutton M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Younkin SG"

Phrase: ":"

Phrase: "Linkage of plasma Abeta42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023745:linkage [Molecular Function]

Phrase: "to a quantitative locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "on chromosome 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008652:Chromosome 10 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "in late-onset Alzheimerss disease pedigrees.Science290"

Phrase: ":"

Phrase: "23032304,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fakhrai-Rad H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Nikoshkov A,"

Phrase: "Kamel A,"

Phrase: "Fernstrom M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zierath JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Norgren S,"

Phrase: "Luthman H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Galli J"

Phrase: ":"

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "identified as a candidate diabetes susceptibility gene"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0919453:Susceptibility Gene [Gene or Genome]
   774   C1332838:Candidate Gene [Gene or Genome]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0017337:Gene [Gene or Genome]
   748   C0205396:Identified [Qualitative Concept]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "in GK rats.Hum Mol Genet9"

Phrase: ":"

Phrase: "21492158,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Farris W,"

Phrase: "Mansourian S,"

Phrase: "Chang Y,"

Phrase: "Lindsley L,"

Phrase: "Eckman EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Frosch MP,"

Phrase: "Eckman CB,"

Phrase: "Tanzi RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Selkoe DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Guenette S"

Phrase: ":"

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "the levels of insulin,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   819   C0202098:insulin levels [Laboratory Procedure]
   819   C0428405:insulin levels [Laboratory or Test Result]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "amyloid beta-protein,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C1750295:beta protein [Genetic Function]
   901   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "and"

Phrase: "the beta-amyloid precursor protein intracellular domain in vivo.Proc Natl Acad Sci U S A100"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C1867626:PROTEIN S, BETA [Gene or Genome]

Phrase: ":"

Phrase: "41624167,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bhathena SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Timmers KI,"

Phrase: "Oie HK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "Voyles NR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027496:NR [Geographic Area]

Phrase: "Recant"

Phrase: "L"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: ":"

Phrase: "Cytosolic insulin-degrading activity in islet-derived tumor cell lines"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   757   C0030281:Insulin Cell [Cell]
   757   C1145751:insulin activity [Molecular Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1561536:*Activity [Idea or Concept]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and in normal rat islets.Diabetes34"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1515981:And [Idea or Concept]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: ":"

Phrase: "121128,"

Phrase: "1985"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Oehler G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bleyl H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Matthes KJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439255:kJ [Quantitative Concept]

Phrase: ":"

Phrase: "Hyperinsulinemia in hepatic steatosis.Int J Obe Relat Metab Disord6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "137144,"

Phrase: "1982 Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439214:fg [Quantitative Concept]
   827   C2348814:FG [Quantitative Concept]

Phrase: "Upward JL,"

Phrase: "Bennett RG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: ":"

Phrase: "In vitro inhibition of insulin-degrading enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0877008:enzyme inhibition [Disease or Syndrome]
   774   C1524081:Enzyme Inhibition [Physiologic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by long chain fatty acids"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   966   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0205166:Long [Qualitative Concept]
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "their coenzyme A thioesters.Endocrinology144"

Phrase: ":"

Phrase: "24042408,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

